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Gastric Cancer (GC) is among the common and fatal cancer in the world. 
DNA repair plays a critical role in protecting the genome of the cell from insults of 
cancer-causing agents. Inherited polymorphisms of DNA repair genes may contribute 
to variations in  DNA Repair capacity (DRC) and genetic susceptibility to different 
cancers. Mammalian cells are constantly exposed to a wide variety of genotoxic 
agents from both endogenous and exogenous sources. In human beings, 70 genes are 
involved in the five major DNA repair pathways: direct repair, NER, BER, mismatch 
repair and double-strand break repair. The X-ray repair complementing defective 
repair in Chinese hamster cells 3 (XRCC3) gene is a member of the RAD51 gene 
family. It encodes an important protein that functions in the homologous 
recombination repair of DNA double-strand break. The Kashmir valley has an 
elevated incidence of GC and its etiology is  not understood fully yet,  though, we are 
ethnically and demographically different from the other states of the country and 
world. The aim of this study was to determine whether single nucleotide 
polymorphism (SNP) of XRCC3 gene (Thr241Met) of exon7, can influence the risk 
of gastric cancer in Kashmiri population. About 80 histopathologically confirmed GC  
cases and 70 healthy controls, age ,gender, ethnicity matched for known genotypes of 
XRCC3 exon7 were analyzed.  Patients medical history and dietary habits were taken 
for the study as well. 
The genotype for this variant was determined using polymerase chain reaction- 
restriction fragment length polymorphisms (PCR-RFLP) in 80 histologically 
confirmed GC patients and 70 frequency-matched healthy controls in Department of 
Biochemistry, Government Medical College srinagar. The XRCC3 genotype and 
allele frequencies were not significantly different between cases and controls (P= 
0.92 for genotype; P= 0:72 for allele). The XRCC3 241Met allele frequency (6.6%) 
was significantly lower in healthy Kashmiri controls than previously reported 
healthy US Caucasian controls (38.9%). Compared with the XRCC3241Thr/Thr 
genotype, the variant XRCC3241Thr/Met and Met/Met genotypes were not 
associated with an increased risk of gastric cancer (adjusted odds ratio (ORa), 1.19; 
95% confidence interval (CI), 0.44-3.18).  These findings suggest that 
polymorphisms of XRCC3 Thr241Met may not play a role in the etiology of GC. 
Further studies with a larger number of subjects and simultaneous measurement of 
different polymorphisms in DNA repair genes in the same pathway are needed. 
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1.1 Cancer 
Cancer is an English term, dissimilated from Greek word “Karkinos” (Sanskrit 
Karkata) for crab, the symbol for fourth zodiacal constellation (The CANCER). The 
word was believed to be first used by Hippocrates, who attributed this affliction to an 
excess of black bile. Cancer was known in old ages, being described in early writings 
of Greeks and Romans. Pathological evidences support the bone tumors in dinosaurs 
and other prehistoric animals but the tumors in Egyptian mummies dating back 5000 
years represent the first known human malignant growths. The vast catalog of cancer 
cell genotypes is a manifestation of following six basic alterations in cell physiology 
(Hanahan et al., 2000) (a) Self-sufficiency in growth signals (b) Insensitivity to growth-
inhibitory (antigrowth) signals (c) Evasion of programmed cell death (apoptosis) (d) 
Limitless replicative potential (e) Sustained angiogenesis and (f) Tissue invasion and 
metastasis. In, general malignant cancers cause significant morbidity and will be lethal 
to the host if left untreated. Exceptions to this appear to be latent, indolent cancers that 
may remain clinically undetectable (or in situ), allowing the host to have a standard life 
expectancy. 
Cancer is a disease that involves dynamic changes in genomes which result in 
abnormal gene expression. Individual cancer susceptibility can be the result of several 
host factors, including differences in metabolism which has been related to the 
enzymatic polymorphisms involved in activation and detoxification of chemical 
carcinogens, the presence of millions of  such polymorphic gene variants in the human 
genome (Sachidanandam et al., 2001, Subramanian et al., 2001) provide extensive 
genetic (and eventually phenotypic) variation affecting both normal physiological 
mechanisms and cancer pathogenesis, loss of functions of DNA repair genes, activation 
of oncogenes by molecular and chromosomal rearrangements in co-ordination with 
cellular transcription factors, mutation in tumor suppressor genes or interaction of 
tumor suppressor gene products with viral oncoproteins, and nutritional status. Besides 
gene polymorphisms and genetic alterations, epigenetic events also play role in cancer 
development as epigenetic regulators alter the activities and abilities of a cell without 
directly affecting and mutating the sequence of the DNA, so perturbation of epigenetic 
balances may lead to alterations in gene expression, ultimately resulting in cellular 
transformation and malignant outgrowth. Thus gene function in cancer can be disrupted 
either through genetic alterations, which directly mutate or delete genes, or epigenetic 
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alterations, which alter the heritable state of gene expression.  
 Clinically, cancer appears to be many different diseases with different phenotypic 
characteristics. As a cancerous growth progresses, genetic drift in the cell population 
produces cell heterogeneity in such characteristics as cell antigenicity, invasiveness, 
metastatic potential, rate of cell proliferation, differentiation state, and response to 
chemotherapeutic agents. At the molecular level, all cancers have several things in 
common, which suggests that the ultimate biochemical lesions leading to malignant 
transformation and progression can be produced by a common but not identical pattern 
of alterations of gene readout.  
Epidemiological studies have shown that upto 90% of all cancers are related to 
environmental factors. Recent estimations suggest that there are over 1.4 million 
sequence variants known as single nucleotides polymorphisms (SNPs) in the human 
genome and other polymorphisms like variable number of tandem repeats (VNTR), 
deletions and gene amplifications in the low penetrance genes which may lead to inter-
individual differences in susceptibility and genetic predisposition to cancer. However 
all individuals exposed to the same type and dose of carcinogen do not develop cancer 
as there is wide inter-individual variability in genes which eliminate the detoxifying 
effect of carcinogens and protect the cells from damage. The study of genetic variants 
in low penetrance group of predisposing polymorphic genes together with 
environmental influences may lead to identification of susceptible subgroups with 
increased risk for cancer in exposed individuals perhaps at low doses of carcinogens. 
Recent estimates show that there are 10.1 million new cases and more than 6.2 million 
deaths, and 22.4 million persons living with cancer (WHO. 2006). Global burden of 
cancer continues to increase and more than 24 million people were living with cancer 
in the year 2002 (Parkin et al., 2005). Incidence of lung cancer has been found to be the 
main cancer in world followed by cancer of the breast (Parkin et al., 2005). Although 
lung cancer is predominant cancer in men it is followed by cancer of esophagus and 
stomach, cervical being the most common cancer in Indian women (PBCRs, NCRP 
Report., 2001).   
1.2  Gastric Cancer 
Gastric cancer is one of the most common cancers worldwide with approximately 
989,600 new cases and 738,000 deaths per year, accounting for about 8 percent of new 
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cancers (Jemal et al ., 2011). Gastric cancer remains one of the most common cancer in 
Asia (Inone et al., 2005, Bae et al., 2002). Gastric cancer is the third most common 
cancer in India and the second leading site of cancer occurrence worldwide (Parkin et 
al., 2001). Gastric cancer has been described as early as 3000 BC in hieroglyphic 
inscriptions and papyri manuscripts from ancient Egypt. The first major statistical 
analysis of cancer incidence and mortality (using data gathered in Verona, Italy from 
1760 to 1839) showed that gastric cancer was the most common and lethal cancer.  
It has remained one of the most important malignant diseases with significant 
geographical, ethnic, and socioeconomic differences in distribution. gastric cancer, like 
all cancers results from an abnormality in the body's basic unit of life, the cell. 
Normally, the body maintains a system of checks and balances on cell growth so that 
cells divide to produce new cells only when new cells are needed. Disruption of this 
system of checks and balances on cell growth results in an uncontrolled division and 
proliferation of cells that eventually forms a mass known as a tumour. 
1.2.1 Symptoms 
Gastric cancer is often asymptomatic. By the time symptoms occur, the cancer has 
often reached an advanced stage. Symptoms are indigestion, loss of appetite, abdominal 
discomfort, abdominal pain in the upper abdomen, bleeding etc 
1.2.2 Causes 
Multiple factors contribute to the pathogenesis of gastric cancer. Marked differences in 
gastric cancer incidence among different ethnic groups living in the same geographic 
area have been observed, pointing to host genetic factors or socio-environmental factors 
peculiar to a particular racial group (Miller et al., 1996). Environmental factors 
including, dietary habits, are important in its development (Lee et al., 1995, Ahn et al., 
1997). Consumption of salted, smoked, pickled and preserved foods rich in salt, nitrite 
and preformed N-nitroso compounds have been reported to be associated with an 
increased risk of gastric cancer (Malik et al., 2011). Infection by Helicobacter pylori is 
believed to be a cause of most stomach cancers while autoimmune atrophic gastritis, 
intestinal metaplasia and various genetic factors are associated with increased risk 
levels. Helicobacter pylori, or H. pylori, is a spiral-shaped bacterium that grows in 
the mucus layer that coats the inside of the human stomach. To survive in the harsh, 
acidic environment of the stomach, H. pylori secretes an enzyme called urease, which 
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converts the chemical urea to ammonia. The production of ammonia around H. 
pylori neutralizes the acidity of the stomach, making it more hospitable for the 
bacterium. In addition, the helical shape of H. pylori allows it to burrow into the mucus 
layer, which is less acidic than the inside space, or lumen, of the stomach. H. pylori can 
also attach to the cells that line the inner surface of the stomach. 
Although immune cells that normally recognize and attack invading bacteria 
accumulate near sites of H. pylori infection, they are unable to reach the stomach lining. 
In addition, H. pylori has developed ways of interfering with local immune responses, 
making them ineffective in eliminating the bacteria (Atherton et al., 2006, Kusters et 
al., 2006). H. pylori  has coexisted with humans for many thousands of years and 
infection with the bacterium is common. The Center for Disease Control and 
Prevention (CDC) estimates that approximately two-thirds of the world’s population 
harbors the bacterium, with infection rates much higher in developing countries than in 
developed nations. A study reported from china supports that gastric cancer is primarily 
determined by environmental factors and develops in a multistep progression of 
precancerous lesions (You et al., 2005).  
Gastric cancer may be seen on gastroscopic exam, endoscopy and computed 
Tomography (CT-SCAN). The diagnosis is confirmed with a biopsy. Abnormal Tissue 
seen in gastroscope examination is biopsied by the Surgeon or Gastroenterologist. 
Treatment and prognosis depend upon the histological type of cancer, the stage (degree 
of spread), and the patient's performance status. Possible treatments include surgery, 
chemotherapy, and radiotherapy. With treatment, the five-year survival rate is 14% 
(Minna et al., 2004). 
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Fig. 1:  Picture (A) showing stomach cancer where the entire stomach is invaded, leading 
to leather bottle-like appearance with blood coming out it. Picture (B) showing 
normal view of stomach by endoscopy procedure (courtesy : wikipedia) 
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 1.3. Gastric carcinoma 
Tumors can be benign or malignant when we speak of "cancer," Benign tumors usually 
can be removed and do not spread to other parts of the body. Malignant tumors, on the 
other hand, grow aggressively and invade other tissues of the body, allowing entry of 
tumor cells into the bloodstream or lymphatic system and then to other sites in the 
body. This process of spread is termed metastasis; the areas of tumor growth at these 
distant sites are called metastases. Gastric carcinoma is the most common cancer in the 
world after lung cancer and is a major cause of mortality and morbidity. Though a 
marked reduction has been observed in the incidence of gastric carcinoma in North 
America and Western Europe in the last 50 years, 5-year survival rates are less than 
20%, as most patients present late and are unsuitable for curative, radical surgery. 
Adenocarcinomas account for approximately 95% of all malignant gastric neoplasms. 
The remaining 5% of tumors are lymphomas, leiomyosarcomas, carcinoids, or 
sarcomas. Gastric adenocarcinomas are divided into 2 types. Type 1 adenocarcinomas 
are intestinal tumors and have well-formed glandular structures. This form of gastric 
carcinoma is more likely to involve the distal stomach and occur in patients with 
atrophic gastritis (Fig.2). It has a strong environmental association. 
1.4. Morphology of the Gastric cancer 
According to modern concepts, gastric cancer is sub-divided into three major 
histological types: intestinal, diffuse and mixed. This classification was proposed by P. 
Laurent, who grouped cancer by its etiology, morphogenesis, macro-and 
microcharactersitics, the specific features of this course, and prognosis of the disease.
Approximately 90% of gastric cancers are adenocarcinomas. These can be classified 
according to their differentiation or according to the histomorphological classification 
of Lauren, which divides the tumours into `intestinal' and `diffuse' (Lauren et al., 
1965). Intestinal tumours are usually exophytic, often ulcerating, and are associated 
with intestinal metaplasia of the stomach. Diffuse tumours are poorly differentiated 
infiltrating lesions which lead to thickening of the stomach (linitisplastica). Patients 
with diffuse-type tumours have a worse prognosis than those with an intestinal type. 
Intestinal cancers appear to be more common in proximal (fundus) localized tumours 
than in distal lesions, while diffuse, poorly differentiated tumours predominate in 
younger patients (Lo et al., 1996). Interestingly, the diffuse type of gastric carcinoma  
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(A) 
 
(B) 
 
(C) 
Fig. 2:  Gastric carcinoma imaging depicts following (A) Polypoid carcinoma of body of stomach, (B) 
Infilitrating carcinoma in stomach, (C) Atrophic gastritis (courtesy : Wikipedia). 
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demonstrates a nearly equal sex ratio, compared with a male preponderance in the 
intestinal form. 
1.5. Inherited predisposition to cancer 
It is well established that most genetic alterations leading to cancer are somatic. 
However, a number of cancers (around 5-10%) are due to inherited cancer 
predisposition syndromes and arise from inherited germline mutations in a cancer 
susceptibility gene (Garber et al., 2005). Inherited cancer predisposition syndromes are 
characterized by multiple affected family members usually at an early age of cancer 
onset, multiple primary cancers and for some rare syndromes, congenital abnormalities 
(Fearon et al., 1997). To date, over 200 hereditary cancer susceptibility syndromes have 
been described, the majority of which are inherited in an autosomal dominant manner 
(Nagy et al., 2004). The lifetime risk of cancer for individuals carrying a mutation in a 
cancer predisposition gene is high and ranges between 50% and 80% (Ponder et al., 
2001). The likelihood of developing cancer depends on the actual gene and the mutant 
allele as well as on other modifying risk factors, both genetic and non-genetic. 
Furthermore, it also depends on the complex gene environment interactions which are 
currently under intense investigation, but at the moment remain poorly understood 
(Ponder et al., 2001). Recently, a number of genome-wide association studies (GWAS) 
have identified common SNP-based variants conferring low to moderate risk for 
cancer. These findings have brought us a step closer to a polygenic model for cancer. 
However, these small effects of multiple genes only explain a small proportion of the 
observed familial clustering for cancer and an extended analysis with a more complete 
range of potential susceptibility variants is needed (McCarthy et al., 2008). 
1.6. Gastric cancer and XRCC3 repair system 
It has been known that genes involved in DNA repair are critical in maintaining the 
integrity of genetic material as well as protection against mutations that could result in 
cancer. Exposure to endogenous and exogenous carcinogens and genotoxic compounds 
can cause damage to DNA. DNA repair process monitors and repairs these DNA 
alterations using the complex mechanisms. The repair systems include base excision 
repair (BER), homologous recombination repair (HRR), nucleotide excision repair 
(NER), mismatch repair, and double strand break repair depending on the type of the 
damaged DNA (Mohrenweiser et al., 1998). The BER process replaces a single 
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damaged nucleotide with a normal residue. Maintenance of genomic integrity in 
mammalian cells depends heavily on the presence of efficient DNA repair systems. 
Reduction in mammalian DNA repair capacity is associated with increasing birth 
defects, cancer and reduced lifespan. Although mutations have long been identiﬁed as 
early events in carcinogenesis, defective DNA repair is also a risk factor for many types 
of cancer. Polymorphisms in several DNA repair genes have been described affecting 
DNA repair capacity and modulate cancer susceptibility by means of gene-environment 
interactions (Claire et al., 2002). Genetic polymorphisms of DNA repair genes are 
thought to result in different phenotypic features compared to the wild type DNA repair 
gene X-ray repair cross-complementing group-3 (XRCC3) corrects defective DNA 
strand-break repair and sister chromatid exchange following treatment with ionizing 
radiation and alkylating agents (Lamerdin et al., 1995). The human gene has 17 exons 
and spans approximately 17 kb and is assigned to14q32.3 (Robert et al., 1995) Fig. 3. 
Homology-directed repair of DNA damage has recently emerged as a major mechanism 
for the maintenance of genomic integrity in mammalian cells. The highly conserved 
strand transferase, Rad51, is expected to be critical for this process. XRCC3 possesses a 
limited sequence similarity to Rad51 and interacts with it. XRCC3 gene participates in 
HRR of DNA double-strand breaks and cross-links (Tebbs et al., 1995, Liu et al., 1998). 
XRCC3 is required for the assembly and stabilization of Rad51 DNA repair gene 
family and has a key role in preventing mutations, chromosomal instability and cancer 
(Khanna et al., 2001). XRCC3-deficient cells do not form Rad51 foci after DNA 
damage and exhibit genomic in stability and increased sensitivity to DNA-damaging 
agents (Masson et al.,2001, Brenemann et al., 2000). Because XRCC3 plays an 
important role in the DNA repair process (Brenemann et al., 2000, Smith et al. ,2003). 
XRCC3 was originally identified as a human gene able to complement the DNA 
damage sensitivity, chromosomal instability and impaired growth of the mutant hamster 
cell line irs1SF. More recently, it has been cloned, sequenced and found to bear 
sequence homology to the highly conserved eukaryotic repair and recombination gene 
RAD51. The phenotype of irs1SF and the identification of XRCC3 as a member of the 
RAD51 gene family have suggested a role for XRCC3 in repair of DNA damage by 
homologous recombination. Homologous recombinational repair (HRR) of a 
specifically induced chromosomal double-strand break (DSB) was assayed in irs1SF 
cells with and without transient complementation by human XRCC3. Complementation  
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Fig. 3: Representative picture showing XRCC3 Gene structure (Source: NCBI) 
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with XRCC3 increased the frequencies of repair by 34- to 260-fold. Studies confirmed 
XRCC3 in HRR of DNA DSB, and the importance of this repair pathway for the 
maintenance of chromosomal integrity in mammalian cells (Brenemann et al., 2000, 
Smith et al., 2003). Growth and development are dependent on the faithful duplication 
of cells. Duplication requires accurate genome replication, the repair of any DNA 
damage, and the precise segregation of chromosomes at mitosis; molecular checkpoints 
ensure the proper progression and fidelity of each stage. Loss of any of these highly 
conserved functions may result in genetic instability and proneness to cancer (Griffn et 
al., 2000). 
 The polymorphisms of DNA repair gene XRCC3 have been reported to be associated 
with the risk of several types of cancer including, colon cancer (Mort et al., 2003, Yeh 
et al., 2005), squamous cell carcinoma of head and neck (Shen et al., 2002, Rousseau  
et al., 2011), lung cancer (Butkiewicz et al., 2001, Misra et al., 2003), Skin cancer 
(Winsey et al., 2000, Duan et al., 2002) and breast cancer (Kuschel et al., 2002, Smith 
et al., 2003). Few studies have investigated the role of polymorphisms of DNA repair 
genes in the etiology of gastric cancer, and none has investigated the role of XRCC3 
polymorphism in this cancer. No data exists, to our knowledge, on their role in 
susceptibility to Gastric cancer among Kashmiri population. This study is therefore the 
first investigative effort in describing the association between XRCC3 exon 7 gene 
polymorphism and Gastric cancer risk.  In this case-control study, the distribution of 
one genetic variant of XRCC3 gene – codon 241 for any risk of development of gastric 
cancer in Kashmiri population with gene polymorphism has been looked into. 
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2.1. DNA damage and its impact on Cancer, aging and longevity 
During the lifespanof the cell, DNA is regularly damaged by endogenous and exogenou
s carcinogens. In order to protect genome stability, cells have evolved DNA repair mec
hanisms. When DNA is exposed to damage, cells activate several pathways suchas cell 
cycle arrest, transcriptional and post‐transcriptional activation of DNA damage respons
e genes including DNA repair genes, and in some cases apoptosis.An inability to repair 
the damage properly due to genetic polymorphisms impairing the DNA repair capacity,
 can lead to genetic instability and potentially modulate individual’s susceptibility to va
rious cancers.  DNA is the genetic ‘instruction manual’ found in all our cells. If DNA 
becomes damaged and is not repaired properly then the cell may get the wrong 
instruction and start to multiply out of control. This can lead to cancer. 
          DNA damage, due to environmental factors, and several normal metabolic 
processes inside the cell, occurs at a rate of 1000 to 1,000,000 molecular lesions per 
cell per day. While this constitutes only 0.000165% of the human genome’s 
approximately 6 billion bases (3 billion base pairs), unrepaired lesions in critical genes 
(such as tumor suppressor genes) can impede a cell’s ability to carry out its function 
and appreciably increase the likelihood of tumor formation (Lodish et al., 2004). 
           The vast majority of DNA damage affects the primary structure of the double 
helix; that is, the bases themselves are chemically modified. These modifications can in 
turn disrupt the molecule’s regular helical structure by introducing non-native chemical 
bonds or bulky adducts that do not fit in the standard double helix (Wilson et al., 1997). 
Unlike proteins and RNA, DNA usually lacks tertiary structure and therefore damage 
or disturbance does not occur at that level. DNA is however, supercoiled and wound 
around packaging proteins called histones (in eukaryotes) and both super structures are 
vulnerable to the effects of DNA damage (Watson et al., 2004).  
          DNA plays a major role in mutagenesis, carcinogenesis and ageing. There are a 
number of chemical events that lead to DNA damage including hydrolysis, exposure to 
reactive oxygen species (ROS) and other reactive metabolites (Fig. 4). These events 
result from metabolic, endogenous processes or are triggered by exposure to exogenous 
chemicals. It is now becoming apparent that mutations due to DNA damage are caused 
by endogenous factors that are modulated by exogenous factors (UV, IR radiations etc) 
and it is probably this combination that plays a major role in many cases of cancer. 
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Oxidatively modified DNA is present in many tissues including tumor tissue (De Bont 
et al, 2004). Oxidative stress occurs when the production of ROS exceeds the body’s 
natural defense mechanisms, causing damage to macromolecules such as DNA. Any 
change in the efficacy of DNA repair will alter the steady-state levels of oxidative DNA 
modifications, which in turn affects the mutation rate and ultimately the cancer 
incidence. Oxidative base damage and single-strand breaks (SSB) are the most frequent 
types of DNA damage caused by ROS (Thompson  et al., 2000) and if not repaired, can 
lead to much more serious double-strand breaks that directly contribute to the 
development of cancer. 
        The replication of damaged DNA before cell division can lead to the incorporation 
of wrong bases opposite damaged ones. Daughter cells that inherit these wrong bases 
carry mutations from which the original DNA sequences is unrecoverable (except in the 
rare case of a back mutation, for example through gene conversion). Extensive 
epidemiological and experimental data suggests that ultraviolet radiation is an 
important environmental carcinogen involved in the initiation and progression of skin 
cancer (Halpern et al., 1999). UV radiation at short wavelengths induces damage in the 
form of cyclobutane pyrimidine dimers and pyrimidine (Mohrenweiser et al., 1998) 
photoproducts. At longer wavelengths it causes single-stranded breaks, DNA – protein 
cross linking and generates free-radicals which cause oxidative damage (Elment et al., 
1996). 
 
Fig. 4: Mechanisms of direct and indirect actions of ionizing radiations inducing DNA 
damage (source: Pubmed) 
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2.2. DNA repair system 
DNA repair systems maintain genomic integrity, which is of vital importance for 
cellular functions. Any kind of failure of these systems has been associated with cancer, 
birth defects and an accelerated rate of ageing (Ronen et al., 2001). Polymorphisms in 
DNA repair genes may result in deficient DNA repair, which in turn leads to 
cumulative genotoxic damage and increased cancer susceptibility (Krajinovic et al., 
2002).  
         DNA repair refers to a collection of processes by which a cell identifies and 
corrects damage to the DNA molecules that encode its genome. In human cells, both 
normal metabolic activities and environmental factors such as UV light and radiation 
can cause DNA damage, resulting in as many as I million individual molecular lesions 
per cell per day (Kreiger et al., 2004). Many of these lesions cause structural damage to 
the DNA molecule and can alter or eliminate the cell’s ability to transcribe the gene 
that the effected DNA encodes. Other lesions induce potentially harmful mutations in 
the cell’s genome, which affect the survival of its daughter cells after it undergoes 
mitosis. As a result, the DNA repair process is constantly active as it responds to 
damage in the DNA structure. When normal repair processes fail and when cellular 
apoptosis does not occur, irreparable DNA damage may occur, including double-strand 
breaks and DNA cross linkages (Bjorksten et al., 1971).  
        The rate of DNA repair is dependent on many factors, including the cell type, the 
age of the cell and the extra cellular environment. A cell that has accumulated a large 
amount of DNA damage, or one that no longer effectively repairs damage incurred to 
its DNA, can enter one of three possible states of  either  senescence (Leeuwen et al., 
2002), apoptosis or unregulated cell division, which can lead to the formation of a 
tumor that is cancerous (Braig et al., 2006). Many genes that were initially shown to 
influence life span have turned out to be involved in DNA damage repair and protection 
(Browner et al., 2004). Failure to correct molecular lesions in cells that form gametes 
can introduce mutations into the genomes of the offspring and thus influence the rate of 
evolution. Mutations in genes involved in DNA repair are also necessary. About 150 
human DNA repair genes have been identified to date (Wood  et al., 2005), but the real 
number is probably higher, since less than 50% of known and putative genes have an 
identified function.  
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          DNA repair systems are responsible for maintaining the integrity of the genome 
in both somatic and germinal cells by minimizing replication errors, deleterious 
rearrangements arising via aberrant recombination and by removing DNA damage 
which might otherwise result in carcinogenesis (Lindahl et al., 1997). Thus, DNA 
repair has a critical role in protecting against mutations that can lead to cancer. Absence 
or incorrect repair can lead to the development of cancer through activation of 
oncogenes, inactivation of tumour-suppressor genes or loss of heterozygosity (Bohr et 
al., 1995). Repair of damaged DNA involves many proteins performing functions 
directly on the damaged DNA, as well as the interaction and interplay with proteins 
involved in regulation of DNA replication and progression through the cell cycle (Fig. 
5) (Lehmann et al., 1998). Numerous studies have shown that genes directly involved 
in DNA repair and maintenance of genome integrity, or genes indirectly involved in the 
repair of DNA damage through regulation of the cell cycle are critical for protecting 
against mutations which lead to cancer.  
        At least four pathways of DNA repair operate on specific types of damaged DNA. 
Base excision repair (BER) operates on small lesions, while the nucleotide excision 
repair (NER) pathway repairs bulk lesions. Mismatch repair corrects replication errors. 
Double-strand DNA break repair (DSBR) actually consists of two pathways, 
homologous recombination (HR) and nonhomologous end-joining (NHEJ). The NHEJ 
repair pathway involves direct ligation of the two double strand break ends, while HR 
is a process by which double-strand DNA breaks are repaired through the alignment of 
homologous sequences of DNA. It is believed that the predominant pathway used for 
removal of oxidized and many of the alkylated bases is BER. 
2.3. DNA repair capacity and inter-individual differences 
Epidemiological studies using functional measurements of DNA repair suggests that 
DNA repair capability is variable within human population (Setlow et al., 1983). As 
inactivating mutations in DNA repair genes are rare (Yu et al., 1999), it has been 
hypothesized that variation in DNA repair capability in the general population is a 
product of combinations of multiple alleles that show subtle variations in biological 
functions (Mohrenweiser et al., 1998). The presence of polymorphic alleles in DNA 
repair genes may alter the repair capacity modifying the biological responses to 
exogenous and endogenous DNA insults, both at cellular and tissue level and the  
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Fig. 5:  Four pathways of DNA repair process that operate on specific types of damaged DNA  
              (Source: Science direct). 
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individual susceptibility in developing different kinds of disease. Inter-individual 
variation in DNA repair capacity has been shown through the use of lymphocyte 
assays. Although findings have been difficult to reproduce, individuals with repair 
capacity of 65-80% of the population mean are more often in the cancer cohorts (Scott 
et al., 1994). The phenotype of reduced repair capacity for one pathway is independent 
of the phenotype for another pathway; this is consistent with DNA repair being 
genetically regulated. Measurement of repair capacity in twins (Pero et al., 1983) and 
the elevated frequency of individuals with reduced repair capacity among relatives of 
cancer patients is further evidence that repair capacity is a genetic trait (Helzouer et al., 
1995). 
          A number of polymorphisms in genes that encode DNA repair proteins have been 
described (Shen et al., 1998). These genes namely XRCC1, ERCC1, XPD, XPF and 
XRCC3, encode enzymes involved in three DNA repair pathways, known to be 
involved in the correction of UV-induced DNA damage. Many of the variants result in 
amino acid substitutions and exist at polymorphic allele frequencies (i.e. allele 
frequencies >0.05). Given the known relationship of DNA repair to cancer, 
polymorphic, variants in the DNA repair enzymes have the potential to be population 
risk factors for cancer because of the large number of individuals affected. 
Polymorphisms in several DNA repair genes have been described affecting DNA repair 
capacity and modulate cancer susceptibility by means of gene-environment interactions 
(Claire et al., 2002). 
2.4 Genetic Polymorphism  
The  coexistence  of  multiple  alleles  at  a  locus  is  called  genetic  polymorphism  
(Lewin et al., 2004).  An  allele  is  usually  defined  as  polymorphic if it  is  present   
at  a  frequency  of  more  than   1%  in  the   population. Polymorphism  caused   by  
the  presence  of  more  than  one  allele  for  the  same gene  which  result  in  more  
than one phenotype in the organisms. The differences between mutations and polymorp
hisms are that polymorphisms  generally  do  not  cause  any  sickness  or  other  
problems  affecting  the reproductive  efficiency  so  that  their  frequencies  in  a   
population  are relatively  high   compared  to  mutations (more  than   1%),  whereas  
a mutation causing a serious disease would affect the reproductive efficiency (Gonzalez 
et al., 1999). That  is  the  reason  why  mutations  are  found  at  extremely  
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low frequency (less than 1%) in populations. The other difference between mutation an
d polymorphism is that, mutations occur at random sites withinthe DNA, whereas poly
morphims are found at specific alleles. 
2.4.1 Mechanism of Genetic Polymorphism  
Genetic  polymorphisms  can  be  categorized  into  functional  and nonfunctional  
polymorphism  depending  on  their  effect  on  protein  profile that  the  gene   is  
translated to a  functional   polymorphism  is  a  change  in  the DNA  sequence  of   a  
gene  that   results  in  different  levels   of  expression  of protein  or  enzyme,  or  in  
alteration of the activity, while a nonfunctional polymorphism results in neither of them 
(Gonzalez et al., 1999).  The functional polymorphisms can be either in the coding or in 
the noncoding regions of the gene. Variations in the coding region of gene have the  
potential  to  alter  enzyme  activity  or  protein  function  by  changing  the primary  
sequence  of  the  protein.  The  non‐coding  regions  of  a  gene  are comprised  of  
introns –which  are  spliced  of  post transcriptionally  and regulatory  regions,  which  
are  not  transcribed  but  regulate  the  level  of expression of the protein. However, if 
the polymorphism occurs at the splice junction,  it  can  affect  the  structure  of  the  
protein  or  enzyme.  Genetic variability  in  these  noncoding  regions  is  associated  
with  altered  levels  of protein  rather  than  changes  in  the  protein  itself  (McKinnon 
et al., 2000).   
2.4.2 Types of Genetic Polymorphism 
Structurally,  polymorphisms  could  occur  as  deletions/insertions (InDel), varying  
number  of  tandem  repeats  (VNTR),  and  single  nucleotide substitutions (SNP).   
Insertion and deletion polymorphism is the insertion or deletion of DNA sequences that 
are 1 to 1000 nucleotides long.  The name microsatellite (VNTR) is usually used when 
the length of the repeating unit is shorter than 10 bp, and the name minisatellites 
(VNTR) is used when the length of the repeating unit is between 10 to 100 bp. The high 
variability of minisatellites makes them useful for genomic mapping.  The most widely 
observed polymorphism in human genome is single nucleotide substitutions (SNP). 
2.4.3 Single Nucleotide Polymorphism (SNP) 
SNP is the substitution of a single nucleotide with a frequency of more than 1% in at 
least one population (Evans et al., 2001). SNPs are distributed throughout the human 
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genome at an estimated over all frequency of one in every 1330 bases in the human 
genome (Lewin et al., 2004). In human, more than 130 genes have been identified 
which codes for proteins of the various DNA repair pathways, and within 80 genes over 
400 SNPS characterized (Mohrenweiser et al., 2003). Because of the importance of 
maintaining  genomic  integrity  in  order  to  prevent  development  of carcinogenesis,  
DNA  repair  genes  have  strong  relevance  in  determining susceptibility  to  cancer  
(Cairns et al.,  1982,  Knudson et al.,  1989,  and  Shields et al.,  1981). For  that  
reason,  SNPs  in  DNA  repair  genes  are  an  important  area  of investigation for 
epidemiology of carcinogenesis. 
2.5 DNA repair gene XRCC3 
XRCC genes, abbreviation of X-ray cross complementing, are components of several 
different damage recovery pathways and XRCC proteins do not show similarity in 
biochemical functions.  
 
 
 
 
Fig 6: Location of XRCC3 gene on the long arm(q) of chromosome 14. 
 X‐ray  cross‐complementing  group  3  (XRCC3)   is  a  member  of homologous  
DNA  repair  mechanisms  and  play  a  key  role  in  that  repair system.  XRCC3  
contains  ATPase  motifs  composed  of  the  Walker  A,  and  B boxes,  and  the  
integrity  of  the  Walker  A  motif  of  XRCC3  is  required  for biological activity and 
governs Rad51C‐XRCC3 complex formation (Yamada et al., 2004). Moreover XRCC3 
protein interacts with Rad51 protein, enabling Rad51 protein multimers to assemble at 
the site of damage (Bishop et al., 1998) In Homo sapiens, this protein coding gene 
maps on chromosome 14, at 14q32.3, (Fig. 6) (Robert et al., 1995). It covers 17870 
bases (NCBI., 2011) on minus strand. The homodimeric protein has a size of 37850 Da 
with 346 amino acids. Its sub cellular location is the nucleus as it accumulates at sites 
of DNA damage. This gene is expressed at high level, 3.8 times the average gene. The 
gene is composed of 17 exons and contains 26 different introns (24 gt-ag, 2 gc-ag) 
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(Lamerdin et al., 1995). Transcription produces 25 different mRNAs, 23 alternatively 
spliced variants and 2 unspliced form. There are 6 probable alternative promotors 
(Zhou et al., 1998), 6 non overlapping alternative last exons and 9 validated alternative 
polyadenylation sites. The mRNAs appear to differ by truncation of the 5' end, 
truncation of the 3' end, presence or absence of 18 cassette exons, overlapping exons 
with different boundaries, alternative splicing or retention of 2 introns. 3125 bp of this 
gene are antisense to spliced gene C14orf153 and KLC1, raising the possibility of 
regulated alternate expression. Four variants were isolated in vivo, although it is a 
predicted target of nonsense mediated mRNA decay (NMD). Twenty-one spliced  and 
2 unspliced mRNAs putatively encode good proteins, altogether 15 different isoforms 
(9 complete, 2 COOH complete, 4 partial), some containing domains RAD51 domain 
(Bork et al., 1997), DNA-repair protein XRCC3; N-terminal [Pfam]. The remaining 
mRNA variant (unspliced) appears not to encode a good protein isoforms are annotated 
using as Met a Kozak-compatible non-AUG(CTG) start, thereby gaining a minimum of 
72 amino acids N-terminal to the first AUG.  
Additionally, XRCC3 was originally identified as a human gene able to complement 
the DNA damage sensitivity, chromosomal instability and impaired growth of the 
mutant hamster cell line irs1SF. More recently, it has been cloned, sequenced and 
found to bear sequence homology to the highly conserved eukaryotic repair and 
recombination gene RAD51. The phenotype of irs1SF and the identification of XRCC3 
as a member of the RAD51 gene family have suggested a role for XRCC3 in repair of 
DNA damage by homologous recombination (Mark et al., 2000). Homologous 
recombinational repair (HRR) of a specifically induced chromosomal double-strand 
break (DSB) was assayed in irs1SF cells with and without transient complementation 
by human XRCC3.Complementation with XRCC3 increased the frequencies of repair 
by 34- to 260-fold. In NHEJ, there is no need to undamaged partner, two DNA ends are 
degraded limitedly at the termini and the DNA ends are ligated together (Khanna et al., 
2001). Since there is no template for the repair of damaged DNA, it is often prone to 
error, and small sequence deletions are usually introduced to the DNA. Schematic 
representation of double strand break repair is given in (Fig. 7). 
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Fig. 7:  Schematic representation of Homologous Recombination end joining and 
Non‐homologous recombination end joining (Source: Ellen et al., 2002). 
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A lot of information about XRCC3 function has been derived from mutant mammalian 
cell lines; to confirm the role of XRCC3 protein on replication similar experiments 
were conducted using permeable XRCC3 gene-knockout DT40 cells (Takata et al., 
2001). As observed in wild-type hamster cells, cisplatin treatment of wild-type DT40 
cells resulted in a dose-dependent reduction in replication, whereas cisplatin treatment 
of XRCC3 DT40 cells did not. Taken together, these data demonstrate that cisplatin 
slows the progression of replication forks in vitro by an active mechanism that requires 
XRCC3. Studies with homologous proteins in yeast have suggested that XRCC3 
functions by stimulating the DNA strand exchange activity of Rad51 (Sung et al., 1997, 
Tsutsui et al., 2000, Liu et al., 1998). In support of this, XRCC3 is required for the 
formation of normal levels of RAD51 nuclear foci following ionizing radiation or 
cisplatin (Bishop et al., 1998; Takata et al., 2001); such foci are believed to reflect the 
formation of Rad51 nucleoprotein filaments that initiate DNA strand transfer during 
recombination. Moreover, overexpression of Rad51 partially corrects the sensitivity of 
XRCC3
-1- 
DT40 cells to ionizing radiation and cisplatin (Takata et al., 2001), consisting 
with XRCC3 promoting Rad51, or a Rad51-like, activity. XRCC3 was inactivated in 
human cells by gene targeting. Consistent with its role in homologous 
recombination, XRCC3
-1-
 cells showed a two-fold sensitivity to DNA cross-linking 
agents, a mild reduction in sister chromatid exchange, impaired Rad51 focus formation 
and elevated chromosome aberrations. Furthermore, endoreduplication was increased 
five- seven-fold in the mutants. The T241M variant of XRCC3 has been associated 
with an increased cancer risk. Expression of the wild-type cDNA restored this 
phenotype, while expression of the variant restored the defective recombinational 
repair, but not the increased endoreduplication. RPA, a protein essential for 
homologous recombination and DNA replication, is associated with XRCC3 and 
Rad52. Over expression of RPA promoted endoreduplication, which was partially 
complemented by overexpression of the wild-type XRCC3 protein, but not by over 
expression of the variant protein. Over expression of Rad52 prevented 
endoreduplication in RPA-over expressing cells, in XRCC3
-1-
 cells and in the variant-
expressing cells, suggesting that deregulated RPA was responsible for the increased 
endoreduplication. These observations offer the first genetic evidence for the 
association between homologous recombination and replication initiation having a role 
in cancer susceptibility (Takashai et al., 2003). 
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XRCC3 defective cells have an increased number of centrosomes, resulting in mis-
segregation of chromosomes (Griffin et al., 2000), which is an important driving force 
in the etiology of cancer (langeaur et al., 1998). Although the XRCC3 T241M protein is 
functional for homologous recombination, it may still be defective in maintaining the 
correct number of centrosomes. Researchers compared centrosome number in a series 
of cell lines derived by transfection from the XRCC3-deﬁcient irs1SF cell line (Tebbs et 
al., 1995), which itself originated from the wild-type AA8 CHO cell line (Fuller et al., 
1988). The cell lines comprised irs1SF complemented with the human XRCC3 (WT), 
XRCC3 T241M or XRCC3 D213N cDNAs, expressed from the pcDNA3.1 vector 
stably integrated into the genome of irs1SF cells (Rafii et al., 2003). At least two 
independent transfected clones were examined in each case in order to avoid clonogenic 
variability, to identify the expressed XRCC3 protein, by western blotting. The irs1SF 
cell line shows no detectable XRCC3 protein, whereas all irs1SF clones expressing 
hXRCC3 variants produce an XRCC3 protein, showing that the human XRCC3 is 
expressed in every clone (Anna et al., 2006). Several studies have examined the 
association between the XRCC3 Thr241Met polymorphism and risk  of  cancer 
(Matullo et al ., 2001,Duan et al.,  2002 , Smith et al.,  2003, Misra et al., 2003,Winsey 
et al.,  2003).  
2.5.1 Functions of XRCC3 gene 
The XRCC3 gene is mapped to 14q32.2 (Tebbs et al., 1995, Zou et al., 2009). The 
gene XRCC3 (X-ray cross complementing group 3) has the task of repairing damage 
that occurs when there is recombination between homologous chromosomes. Repair 
of recombination between homologous chromosomes plays an important role in 
maintaining genome integrity, although it is known that double-strand breaks are the 
main inducers of chromosomal aberrations. Changes in the XRCC3 protein lead to 
an increase in errors in chromosome segregation due to defects in centrosomes, 
resulting in aneuploidy and other chromosomal aberrations, such as small increases 
in telomeres. The XRCC3 (X-ray cross complementing group 3) gene is needed to 
repair damage caused when recombination occurs between homologous 
chromosomes (Loizidou et al., 2008, Andreassi et al., 2009). The repair of 
recombination between homologous chromosomes is a mechanism that fixes various 
types of DNA damage. The large number of repeated sequences can potentially lead 
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to a large number of undesirable interactions between chromosomes. The repair of 
recombination between homologues plays an important role in maintaining genome 
integrity. Although it is known that double-strand breaks are the main inducers of 
chromosomal aberrations, the mechanisms by which these are formed are still 
unresolved (Griffin et al., 2004). Deficiencies in the XRCC3 protein lead to an 
increase in errors in chromosome segregation due to defects in centrosomes, 
resulting in aneuploidy and other chromosomal aberrations such as small increases 
in telomeres (Thacher et al., 2005). XRCC3 is an important component in the repair 
machinery via homologous recombination. Changes in this machine due to the 
presence of polymorphisms lead to damage that results in tumor development (Jiao 
et al., 2008). The XRCC3 gene has a sequence variation in exon 7 (C18067T), 
which results in an amino acid substitution at codon 241 (Thr241Met) that may 
affect the enzyme's function and/or its interaction with other proteins involved in 
DNA damage and repair (Matullo et al., 2001).  The XRCC3 Thr241Met 
polymorphism (rs861539) located in exon 7 is characterized by the substitution of 
thymine (T) to cytosine (C) at codon 241, leading to a change of threonine (Thr) to 
methionine (Met), and could affect enzyme function and/or its interaction with other 
proteins involved in repair of DNA damage (Matullo et al., 2001, Jiao et al., 2008, 
Andreassi et al., 2009). Pierce et al. (1999) demonstrated that cell lines defective in 
XRCC3 had a 25-fold decrease in homology-directed repair of DNA double-strand 
breaks. Mutant cell lines deﬁcient in XRCC3 experienced high frequencies of 
spontaneous chromosomal aberrations (Tebbs et al., 1995, Liu et al., 1998, Fuller et 
al., 1998). In addition, these cell lines have shown an array of sensitivities to DNA 
damaging agents ranging from modest sensitivity, caused by alkylating agents and 
ionizing and ultraviolet radiation, to extreme sensitivity due to DNA crosslinking 
agent (Fuller et al., 1998, Caldecott et al., 1991). Shen et al. (2003) recently 
identiﬁed a C to-T substitution in exon 7 at position 18067 of XRCC3, a 
polymorphism that results in a threonine-to-methionine amino acid substitution at 
codon 241. The  XRCC3  gene   product  is  a  member  of  the  RAD51‐  related  
gene family, and directly interacts with Rad51 (Liu et al., 1998,  Brenneman et 
al., 2000 and Schild et al.,  2000).  XRCC3  protein  associates  directly  with  
DSBs  and  recruit Rad51  (Forget et al.,  2004) and  XRCC3‐Rad51  complex  
cooperatively modulate the progression of the replication forks on damaged chromos
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omes  (Henry et al.,  2003).  Deficiency  of  XRCC3  gene  resulted  in  increased  
hypersensitivity  to  ionizing  and  UV   radiations  as  well  as  mono and  
bifunctional alkylating agents (Xu et al., 2005, Alsbeih et al., 2007) 
2.5.2 Role of XRCC3 gene in Homologous Recombination pathway. 
Homologous recombination (HR) is essential for the accurate repair of DNA double-
strand breaks (DSBs), potentially lethal lesions. HR takes place in the late S-G2 phase 
of the cell cycle and involves the generation of a single-stranded region of DNA, the 
intact strand as a template, branch migration and resolution. It is investigated that 
RecA/Rad51 family proteins play a central role (Fig.8). The product of the XRCC3 
gene, paralogue of Rad 51 family, functions in the homologous recombination repair 
(HRR) for double-strand breaks (DSBs) and cross-link repair in mammalian cells 
(Dianov et al., 2003). During HRR the XRCC3 protein interacts with the Rad51C 
protein and possibly with theRad51 protein itself, enabling Rad51 protein multimers to 
assemble at the site of damage (Brenneman et al., 2002). Since XRCC3 protein 
performs a very important function in the HR DNA DSB repair pathway. In the HR 
pathway, XRCC3 is earlier than RAD51 to localize at sites of DSB damage, and 
subsequently functions to promote the assembly of active RAD51 repair complexes, 
namely RAD51 foci (Fig. 9) (Forget et al., 2004). Once RAD51 foci are formed, 
mammalian cells use the sister chromatid as the template of preference over a 
homologous or heterologous chromosome. Lack of the XRCC3 gene will result in 
decreased function of HR (Pierce et al., 1999) and defects in chromosome segregation 
(Griffin et al., 2000). Hence, XRCC3 mediates RAD51-dependent HR necessary to 
repair DNA damage that may result in carcinogenesis if left unrepaired or misrepaired.  
Homologous recombination repair (HR) plays an important role in the repair of DNA 
double strand breaks (DSBs) caused by ionizing radiations or from break down of 
stalled replication forks. Accurate DSB repair, using sister chromatid as template, is 
necessary for the maintenance of genomic stability, and defects in this process can lead 
to the introduction of mutations, chromosomal translocations, apoptosis, and cancer. 
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Fig. 8:  Role of XRCC3 gene and Homologous Recombination repair, schematic illustration 
            (source: Wikipedia) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9:   Schematic description of repair pathways genes and interactions between XRCC3 gene and  
              Rad51 family (source: Wikipedia)  
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2.6 Incidence and Mortality  
Gastric cancer is the second-most common cancer among men and third-most among 
females in Asia and worldwide (Table. 1) (Ferlay et al., 2008). Gastric cancer is one of 
the most common cancers worldwide with approximately 989,600 new cases and 
738,000 deaths per year, accounting for about 8 percent of new cancers (Jemal et al 
.,2011). Approximately 21,320 patients are diagnosed annually in the United States, of 
whom 10,540 are expected to die (Table. 2) (Siegal et al., 2011). Gastric cancer is less 
common in the United States and other Western countries than in countries in Asia and 
South America. Overall, gastric cancer incidence rates are decreasing. (Fig. 10). The 
worldwide incidence of gastric cancer has declined rapidly over the recent few decades 
(Haenszaz et al., 1958, Munoz et al., 1971, Hirayama et al ., 1975, Waterhouse et al.,  
1976). Part of the decline may be due to the recognition of certain risk factors such as 
H. pylori and other dietary and environmental risks. However, the decline clearly began 
before the discovery of H. pylori. The decline first took place in countries with low 
gastric cancer incidence such as the United States (beginning in the 1930s), while the 
decline in countries with high incidence like Japan was slower. In the United Kingdom, 
there was a consistent decline in incidence of gastric cancer, with a reduction  from 
1.14 in 1971 to 1975 to 0.84 in 1996 to 2000 in men, and 1.18 in 1971 to 1975 to 0.81 
in 1996 to 2000 in women (Fitzsimmons et al., 2007). In China, the decline was less 
dramatic than other countries; despite an overall decrease in gastric cancer incidence, 
an increase has been observed in the oldest and the youngest group, and a less 
remarkable decline has been observed among women than in men (Jemal et al., 2006). 
Of note is that the age of onset of developing gastric cancer in Chinese population is 
younger than that in the West. In the United States, risk factors for noncardia gastric 
cancer include male gender, non-white race, and older age (Schlansky et al.,2011). 
Between 1977 and 2006, the incidence rate for noncardia gastric cancer in the United 
States declined among all race and age groups except for whites aged 29 to 39 years for 
whom it increased (Anderson et al., 2010). The rise in incidence of noncardia gastric 
cancer among those at 25 to 39 years is noteworthy since this may signal the 
introduction of new environmental factors. Gastric cardia cancer, which was once very 
uncommon, now constitutes nearly half of all stomach cancers among white males in 
the United States. Infection with H. pylori is the primary identified cause of gastric 
cancer. Other factors that increase the risk for gastric cancer include chronic gastritis, 
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older age,  male sex,  a diet high in salted, smoked, or poorly preserved foods and low 
in fruits and vegetables, tobacco, smoking, anemia, a history of stomach surgery for 
benign conditions, and a family history of stomach cancer (Forman et al ., 2006, 
Brenner et al., 2009). It is estimated that 21,520 men and women (13,120 men and 
8,400 women) will be diagnosed with and 10,340 men and women will die of cancer of 
the stomach in 2011 (Howalder et al., 2011, Malik et al., 2011). 
Gastric cancer is the most aggressive malignant tumors of gastrointestinal tract with 
diverse risk factors and incidence patterns. Within the Indian subcontinent, the valley of 
Kashmir presents a strikingly different picture, where incidence of gastric cancer has 
been reported to exceed 40% of all cancers and incidence is 3-6 times higher than 
various metropolis cancer registries in India (Khuroo et al., 1992). The people of the 
Kashmir valley have many unique dietary features which are different from rest of 
world. Salted tea used by people is prepared by using baking soda (sodium bicarbonate) 
along with common salt (sodium chloride) and boiled for few hours before consuming. 
Some of the genetic and environment factors have been reported to be associated with 
an increased risk of gastric cancer in Kashmir valley (Siddiqui et al., 1992,  Malik et 
al.,  2011). 
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Table. 1: Stomach Cancer Incidence and Mortality Worldwide in 2008 ⃰ . 
Estimated numbers 
(thousands) 
   MALES  FEMALES 
 CASES DEATH CASES DEATH 
     
World 640 463 348 73 
More developed regions 173 110 101 70 
Less developed regions 467 353 246 202 
WHO Africa region 
(AFRO) 
10 9 8 8 
WHO Americas region 
(PAHO) 
54 40 35 27 
WHO East 
Mediterranean region 
(EMRO) 
15 14 8 7 
WHO Europe region 
(EURO) 
99 79 66 54 
WHO South-East Asia 
region (SEARO) 
39 37 28 25 
WHO Western Pacific 
region (WPRO) 
420 282 201 150 
IARC membership (22 
countries) 
190 119 110 75 
United States of America 13 6 8 4 
China 315 231 148 121 
India 21 20 13 12 
European Union (EU-27) 50 37 32 24 
 
     
*Source:  (Globoscan., 2008) 
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Table 2: Incidence and mortality 2010 (American Cancer Society) 
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Fig. 10:  Cancer Incidence and mortality (females and  males) worldwide 2010 as given by 
                       Globocan. 
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2.7 XRCC3 polymorphism and risk of possible cancer  
A common polymorphism in exon 7 of the XRCC3 gene results in an amino acid 
substitution at codon 241(Thr241Met) that may affect the enzyme’s function. The 
XRCC3 variant allele has been identified in healthy individuals at a frequency ranging 
from 0.23 to 0.38 (Shen et al., 1998, David-Beabs et al., 2001), and has been associated 
with increased risk of melanoma (Winsey et al., 2000), bladder cancer (Matullo et al., 
2001), breast cancer (Smith et al., 2003) and lung cancer (Jacobsen et al., 2004, Lee et 
al., 2007) in a meta-analysis on Thr241Met reported that Met241 is associated with risk 
of developing breast cancer in Asian and Caucasian populations. The Thr241Met 
substitution is the most thoroughly investigated polymorphism in XRCC3 due to the 
C>T transition at exon 7. Functional data also suggest that the polymorphism may be 
associated with slightly decreased DNA repair capacity (Jara et al., 2010). Kiuru et al. 
(2008) studied the XRCC3 Thr241Met polymorphism in samples of nervous system 
tumors and concluded that the genotype Thr/Met and homozygous Met/Met are 
associated with increased risk for developing this kind of tumors. Zhou et al. (2009) 
conducted a case-control study in a Chinese population on the XRCC3 Thr241Met 
polymorphism in 771 samples of gliomas and 752 control samples, concluding that the 
presence of genotype Met/Met may contribute to the development of gliomas. The 
XRCC3 Thr241Met polymorphism was analyzed in samples from breast cancer. The 
result demonstrated that the presence of the polymorphism does not interfere with 
disease development (Loizidou et al., 2008). 
Several studies have examined the relationship between XRCC3Thr241Met polymorp-
hism and risk of certain cancers. Moreover  there  are  numerous  studies  in  some  of  
which  XRCC3 Thr241Met polymorphism have been a risk factor, in some of which 
it has been a protective factor and in some it does not have any association with the  
disease  development.  Studies about XRCC3 polymorphisms and their interaction 
with the related diseases were listed in (Table. 3), below. However the results from  
these  previous  studies  are  conflicting.  For  this  reason,  additional  studies  to  
address  the  role  of  XRCC3  Thr241Met  polymorphism  in  human  
carcinogenesis are needed.   
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Table. 3.  Genetic polymorphism of XRCC3 Thr241Met gene and its interaction with various 
types of cancers.* 
 
 
S.No Cancer types Association No.of control References 
 
 
    
1. Lung cancer Increased risk 190 Wang et al.,  2003 
2. Bladder cancer Increased risk 209 Stern et al.,  2002 
3. Acute Myeloid 
Leukemia 
Increased risk 186 Seedhouse et al.,  2004 
4. Colorectal cancer Increased risk 100 Krupa et al.,  2004 
5. Breast cancer Increased risk 1826 Kuschel et al.,  2002,  
 
Smith et al.,  2003 
6. Acute lymphoblastic 
Leukemia 
Protective role 193 Cihan et al.,  2010 
7. Bladder cancer Protective role 214  Shen et al.,  2003 
8. Colorectal cancer Protective role 128 Mort et al.,  2003 
9. Skin cancer Protective role 873 Han et al.,  2004 
10. Supraglottic cancer Protective role 172 Benhamou et al., 2004 
11. Lung cancer No association 272 Jacobsen et al.,  2004 
12. Gastric cancer No association 166 Shen et al.,  2004 
13. Cutaneous Malignant 
Melanoma 
No association 319  Duan et al.,  2002 
14. Colorectal cancer No association 725 Tranah et al., 2004 
 
* (Source: Cihan et al., 2010) 
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2.7.1 XRCC3 and its relation with Gastric cancer 
DNA repair pathways are responsible for maintaining the integrity of the genome in 
face of environmental insults and general DNA replication errors, playing a role in 
protecting it against mutations that lead to cancer (Lindhal et al., 2000). So, 
polymorphisms of DNA repair enzymes, which may alter the function or efﬁciency of 
the DNA repair, may contribute to an increased risk of environmental carcinogenesis 
(Mohrenweiser et al., 1998). These low-penetrance susceptibility genes have common 
variants and interact with environmental factors, contributing as a major factor to the 
populational incidence of cancer (Shields et al., 2000). The polymorphism in genes that 
participate in different DNA repair pathways, such as XRCC3 (Shen et al., 1998), have 
been  identiﬁed and related to cancer susceptibility. Protein XRCC3 functions in the 
DNA double-strand break (DSB) and cross-link repair (Thompson et al., 2002) and 
interacts and stabilizes Rad51 (Schild et al., 2000), one of the key components of the 
homologous repair (HR) pathway. The HR pathway uses a second intact copy of a 
homologous chromosome as a template to copy the information lost at the DSB site, 
resulting in a high-ﬁdelity process and preventing chromosomal aberrations 
(Christmann et al., 2003). The main polymorphism in this gene involves the change of 
threonine (Thr) to methionine (Met) at codon 241 in exon 7 (Shen et al., 1998). Little is 
known about the functional consequences of this variation, although some studies 
observed a positive relation between the Thr241Met polymorphism and an increased 
risk for skin (Winsey et al., 2000), bladder (Matullo et al., 2001), breast (Smith et 
al.,2003) and lung (Jacobsen et al., 2004) cancers. So far, the investigations about 
interactions between XRCC3 polymorphism and environmental  carcinogenesis have 
produced  scarce  and  conflicting results (Ratnasinghe et al., 2004, Duan et al., 2002, 
Shen et al., 2004, Sanyal et al., 2004), showing the functional complexity of these 
variants, that can include their interaction with environmental factors, thus modulating 
the susceptibility to cancer. Regarding gastric cancer, only a few studies were 
conducted to investigate its association with XRCC3 variants (Shen et al., 2000, 
Ratnasinghe et al., 2004, Shen et al., 2004, Fang et al., 2010). Currently there
 
are no 
reports on the association between XRCC3 polymorphisms
 
and Gastric cancer risk.  
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2.7.2 Related risk factors 
Gastric carcinogenesis is a multistep process composed of genetic and epigenetic 
alterations (Tahara et al., 1993). Gastric cancer can develop in any part of the stomach 
and may spread throughout the stomach and to other organs; particularly the 
oesophagus and the small intestine. As per Cancer, World Health Organization (Feb 
2006), Stomach cancer causes nearly one million deaths worldwide per year. In the 
global incidence stomach cancer is second most common tumour (Chan et al., 2006). 
India, overall, is deemed to be a low incidence (<6.7 /100,000) country but there are 
regions, like Kashmir, with a particularly high incidence (Sipponen et al., 1983, 
Khuroo et al., 1992). Clinical experience has revealed very high prevalence of gastric 
cancer in Kashmir. It is suspected that several risk factors are  involved including diet, 
gastritis, smoking, intestinal metaplasia and Helicobacter pylori infection. It is more 
common in men. Kashmir valley is one of the high incidence areas (Khuroo et al., 
1992) where different environmental  and dietary habits play an overwhelming role in 
the  development of gastric cancer. These include intake of sun-dried vegetables of 
Brassica family (Hakh), pickled vegetables (Anchar) and hot salted tea, which contains 
potentially high content of carcinogenic compounds like nitrosamines (Kumar et al., 
1992). Personal habits like smoking of hukka/cigarette increases the risk of developing 
gastric cancer (Khuroo et al., 1992). In Kashmir, the most important specific food habit 
is consumption of large quantities of hot salted tea. The use of sodium bicarbonate at 
the time of boiling the tea leaves and the further addition of common salt to the 
prepared tea cause one to suspect that the tea does more than cause thermal injury to 
oesophageal epithelium. Common salt (NaCl) is a well-known irritant of gastric 
epithelium and has been considered a risk factor for gastric cancer (Khuroo et al., 
1992).The presence of N-nitroso compounds (found in most of the customary dietary 
items of a native Kashmiri) in the stomach has been incriminated as a possible 
etiological factor in the genesis of gastric cancer (Mirvish et al., 1972, Siddiqi et al 
1992). As per Census of India 1981, Series 8, Jammu and Kashmir; one of the factors 
include the peculiar geography of the valley (situated at an altitude of 1800-2400 m 
above the sea level), and severe cold winter may have a bearing on the etiology. Gastric 
cancer most often develops in the context of chronic inflammation, named "chronic 
gastritis" in the stomach. However, inflammation in this organ is by a crucial agent i.e 
bacterium, Helicobacter pylori (IARC., 1994) 
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2.7.3 Gastric cancer and its association with genetic factors 
Globally literature suggests that polymorphism in genes involved in inflammation viz 
interleukin (Hold et al., 2007) toll-like receptor 4 (Magnusson et al., 2001), human 
leukocyte antigen (Li et al., 2005),metabolic phase I enzyme viz CYP1A1 (Gonzalez et 
al., 2002), metabolic phase II enzyme viz GSTM1, GSTT1 (Glutathione-S-transferase) 
(Shen et al., 2001) and NAT1, NAT2 (N-acetyltransferase), DNA repair Viz XRCC1 
(Malik et al., 2011) are involved in development of gastric cancer. Indian studies on 
this topic are limited because of inadequate sample size, improper study designs and 
inability to controls for confounders. Only small numbers of polymorphism were 
investigated in all these studies. Most of the Indian studies have used RFLP method for 
genotyping while studies conducted outside India have used Taqman and Illumina 
assays for genotyping. Evidence for a genetic predisposition to gastric cancer comes 
from both epidemiological studies and case reports of gastric cancer families. 
Systematic case-control and cohort analyses of gastric cancer patients have shown that 
the risk of gastric cancer in first-degree relatives is increased 2–3-fold (Woolf et al., 
1954, Videbaek et al., 1954, Macklin et al., 1960, Zangheri et al., 1990, La et al., 1992, 
Goldgar et al., 1994, Nagase et al., 1996, Hoshino et al., 1985, Palli et al., 1985, Karner 
et al., 1997). An association between gastric cancer and other cancers (colorectal and 
CNS tumours) has been observed in some of these studies (Goldgar et al., 1994, Karner 
et al., 1997). These associations suggest the presence of predisposition genes with 
pleiotropic effects. The risk of gastric cancer in relatives of patients has been shown to 
be dependent upon histology (Palli et al.,1985). Relatives of patients with intestinal 
disease have a 1.4-fold increase in risk, compared with a 7.0-fold increase in risk in 
relatives of patients with diffuse disease (Palli et al., 1985). This suggests that 
differences in histology reflect, in part, a greater hereditary basis in diffuse gastric 
cancer. 
2.8 Aim of This Study 
As per Cancer, World Health Organization (Feb, 2006), gastric cancer causes nearly 
one million deaths worldwide per year. In the global incidence stomach cancer is 
second most common tumour (Chan et al., 2006). In India it is believed to be a low 
incidence (<6.7 /100,000) country but there are regions, like Kashmir, with a 
particularly high incidence (Sipponen et al., 1983, Khuroo et al., 1992). Observation  
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of  association  between  some  cancer  types  and  DNA  repair defects suggested 
the DNA repair genes as candidate cancer  susceptibility genes. Homologous 
recombination repair is the most important mechanism for the sake of the cell.  It 
is well established that individuals having a modified ability to repair double 
strand breaks are at an increased susceptibility to cancer. Therefore, polymorphisms in 
genes encoding DSB repair molecules have strong relevance in  determining 
susceptibility t o  cancer. 
As described in more detail previously, XRCC3 is susceptible enzyme due to the 
dual roles in repair of double strand DNA breaks.  Genetic  polymorphisms  altering  
the  activity  or  the  structure  of XRCC3   may   modify   the   individual’s   
susceptibility   for   the gastric cancer. Polymorphisms of XRCC3 have been widely 
studied in relation to various cancer types as risk modifiers. However, so far, there 
have been no reports evaluating the clinical significance of XRCC3 genetic 
polymorphisms for the risk of gastric cancer. Therefore, this study focused on the 
effects of XRCC3 genetic polymorphisms, alone, as risk modifier for the development of 
gastric cancer and therefore the  aims related with the present study included: 
 
 Investigation of association of XRCC3 Thr241Met (codon241) 
polymorphism in control and case group, and determination of the effects 
of this polymorphisms on the risk of  development  of  gastr ic  Cancer 
(if any).   
 Investigation  of  the  interaction  between  XRCC3 Thr241Met  genetic 
polymorphisms   with  non‐genetic  factors  such  as   age  of patients, 
gender, smoking status of patients, residence, salty food, Helicobacter 
pylori (if any) etc. 
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3.1 MATERIAL 
3.1.1 STUDY POPULATION  
Subjects were recruited at Sheri- Maharaja Hari Singh Hospital (SMHS), Srinagar 
Kashmir. The recruitment process was initiated following approval by Departmental 
ethical committee of Biochemistry Government Medical College (GMC) Srinagar. The 
diagnosis of gastric cancer was based on the standard histopathalogical criteria. 
Controls were recruited from the different wards of Sheri- Maharaja Hari Singh 
Hospital (SMHS) and Associated Government Medical College (GMC) Hospitals, 
following the referral pattern of sex and age matched patients. None of the controls had 
a personal history of malignancy. 
 SUBJECTS 
Criteria adopted for selecting the cases and controls 
The criteria for including or excluding a subject in the study were formulated prior to 
the commencement of the study.  
 Cases 
All the histopathologically confirmed Gastric cancer patients were included irrespective 
of cancer stage or age. In our case control males, cases were 50 male patients and 40 
female patients. 
Exclusion criteria 
Under the following conditions the patients were not recruited in the study; 
 Patients suffering from any disease that affected their life style. 
 Patients who had received prior chemo or radiotherapy. 
 Patients not belonging to Kashmir valley. 
 Who did not agree to participate 
Inclusion Criteria 
 Histopathologically proven gastric cancer patients. 
 Patients who were willing to take part in the study. 
 Patients belonging to Kashmir valley. 
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 Controls 
Controls were matched to the cases by age and gender. 
Exclusion criteria 
 Patients who never suffered from any kind of malignancy. 
 Patients who did not agree to participate. 
Inclusion criteria 
 Residents of the Kashmir valley. 
 Matched gender ratio with the cases. 
3.1.2. COLLECTION OF BLOOD SAMPLES 
Individuals who gave consent to participate in this case-control study were enrolled at 
the SMHS. Blood sample was collected from both the cases and the controls. After 
proper consent from each subject, 3-4 ml of blood was collected in EDTA vial. The 
samples were stored at -80
0
 C until processed.DNA was extracted from peripheral 
leukocytes according to Phenol-Chloroform method (Sambrook and Russel, 2001). 
Note: Chemicals used and preparation of reagents are illustrated in Appendix.  
3.2. METHODS 
3.2.1. DNA extraction from Blood 
1. To 3 ml of blood, 9 ml of erythrocyte lysing buffer was added. 
2. The contents were shaken gently, incubated for 30 min on ice, and centrifuged 
at 4000 rpm for 10 min. 
3. The supernatant (blood waste) was removed and the pellet was resuspended in 9 
ml of erythrocyte lysis buffer and centrifuged for 10 min at 4000 rpm. 
4. The supernatant was discarded. 5 ml of SE-buffer, 20 µl proteinase K 
(10mg/ml) and 100 µl 20% SDS were added to the pellet. The contents were 
shaken gently and incubated overnight at 37
0
C in a water bath/Incubator. 
During this step the white blood cells membranes are denatured and DNA goes 
out in solution. 
5. Next day, equal volume of Tris-equilibrated (TE) Phenol was added to the 
contents and shaken gently for 10 min. The tubes were centrifuged at 3000 rpm 
for 5 minutes. 
  Material  and Methods 
 
                                                                                                                                                                40 
6. The supernatant was aspirated and transferred into a new tube. Equal volume of 
phenol/chloroform/isoamyl alcohol (25:24:1) was added to the contents. The 
emulsion was then centrifuged for 10 min at 2000 rpm with minimal extracted 
into the supernatant and proteins separated into the lower phase. 
7. The aqueous phase was removed using a Pasteur pipette without disturbing the 
protein interface and was transferred into a new tube to which equal volume of 
chloroform/isoamylalcohol (24:1) were added. The tubes were shaken for 10 
min and centrifuged at 3000 rpm for 5 min. 
8. The upper aqueous phase (containing DNA) was transferred into a clean and 
sterile conical centrifuge tube using a sterile Pasteur pipette, followed by the 
addition of 300 µl of chilled 3M sodium acetate ( pH 5.2) and an equal volume 
isopropanol along the sides of the tube. 
9. DNA was precipitated by gentle swirling of the tube and observed visually as a 
white thread like strand that was spooled out using a cut-tip and transferred into 
a 1.5 ml eppendorf tube. 
10. The DNA was washed twice in 70% ethanol by inversion to clean it from any 
remaining salts and the tube was centrifuged at 11000g for 4 min. The 
supernatant was discarded without disturbing the DNA pellet. 
11. After discarding the supernatant the pellet was air dried from excess ethanol by 
leaving the tubes open and inverted. 
12. The dried pellet was re-suspended in 300µl of DNA storage buffer and left 
overnight at 37
0
C for complete dissolution. 
13. DNA purity and concentration was determined spectrophotometrically 
(pharmacia, Gene Quant) by measuring the absorbance at 260nm.Purity was 
assessed by the A260/280 ratio. 
14. The quality of extracted DNA was determined by electrophoresis, on 1% 
agarose gel. 
15. DNA was dissolved in TE-storage buffer at -200C for longer storage and shelf 
life. 
  3.2.2. DETERMINATION OF CONCENTRATION, PURITY AND QUALITY OF GENOMIC DNA 
 Qualitative Analysis 
The quality of the genomic DNA was examined by gel electrophoresis using 0.8 % 
agarose gel. Two microlitre of each DNA sample was mixed with 1µl of 1X DNA 
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loading dye (1X loading dye consists of 4.16 mg bromophenol blue, 4.16 mg xylene 
cyanol and 0.66g sucrose in1ml water) and was loaded in the gel. Electric current was 
applied at 20 volt until DNA entered in to the gel and was raised to 50 volt for rest of 
the run. Run was stopped when the dye had travelled nearly 2/3rd of the gel. Gel was 
visualized by a Gel doc system (AlphaimagerTM 2200, Alpha Innotech Corporation) 
under UV light and picture was captured by using CCD camera system. 
 Quantitative Analysis 
The quantity of the DNA was estimated by making appropriate dilutions to determine 
the optical density (OD) at 260nm and 280 nm by double beam spectrophotometer 
(Spectron 2206) and the concentration was determined using equation: 
DNA (µg/ml) = A260 x 50 x dilution factor 
The ratio of A260/A280 was calculated and the DNA samples for which the ratio was 1.7-
1.9 was kept for the future use. The DNA was stored at 4
o
C for a short time but the 
vials were kept at -20
o
C for longer duration storage. 
3.2.3. AGAROSE GEL ELECTROPHORESIS 
 The edges of clean, dry glass plate were sealed with tape to form a mold, and 
were set on a horizontal section of the bench. 
 Sufficient electrophoresis buffer (1xTAE) was prepared to cast the gel and to 
fill the electrophoresis tank.  
 Eight hundred milligrams of agarose was dissolved in 100 ml of 1x TAE buffer 
and heated to boil in oven until a clear transparent solution was formed. 
 After removing from the oven the solution was allowed to cool to 50-60oC and 
then a small volume (5µl) of ethidium bromide was added as visualizing agent. 
 The warm agarose was poured into the mold. An appropriate comb was 
positioned for forming the sample slots in the gel when the agarose was added 
to the mold. 
 The gel was allowed to set completely (30-45 min), then a small amount of 
TAE buffer was poured on top of the gel and the  comb was carefully removed. 
TAE buffer was poured, after removing tape also, and gel was mounted in the 
tank. 
 Sample was mixed with few drops (2-3 µl) of 6Χ gel loading buffer. 
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 Sample was loaded slowly and carefully into the slot of submerged gel using 
disposable loading tips. 
 The lid of gel tank was closed and electric leads connected so that the DNA 
would migrate toward positive anode (red lead).Voltage gradient of 1-5 V/cm 
was applied (distance measured from cathode to anode). The gel was allowed to 
run until the bromophenol blue and xylene cyanol migrated an appropriate 
distance through the gel. 
Pattern of separation was visualized by a Gel doc system (AlphaimagerTM 2200, 
Alpha Innotech Corporation) under UV light and picture was captured by using CCD 
camera system. Samples containing high molecular weight DNA with no 
fragmentation/ shearing and without any apparent contamination or streaking were 
selected for further analysis. 
3.3 Primers for genotyping 
Primers used throughout the study were selected by literature search and were 
derived from known sequences of human. The primer pairs were purchased  from 
(MERCK, Germany). Primers stocks were brought to 100 pmol/µl  concentration 
and stored at ‐20 0C. Aliquots of 6.5 pmol/µl concentration were prepared and used 
for PCR. 
3.3.1. GENOTYPING OF XRCC3 GENE POLYMORPHISM 
Once it was confirmed that the genomic DNA is present and concentration and purity is 
also desirable, the desired fragment of DNA i.e. exon 7 containing the codon 241 in 
XRCC3 gene, were amplified by Polymerase Chain Reaction (PCR). The standard 
protocol for PCR was used; however the technique was standardized or optimized for 
available environmental conditions. After standardizing all the parameters of technique 
like varying annealing temperature,  dNTP,  primer and template concentration, regions 
containing the codons 241 in XRCC3 gene were amplified. PCR was performed in total 
volume of 25µl. The PCR reactions were composed of 50-150 ng genomic DNA, 
0.1mM dNTPs, 6.2pmoles/µl of each primer, 1.5mM MgCl2 and 1U/µl of Taq 
polymerase in 1x PCR buffer as shown in (Table.4,5). Reaction mixture in PCR tubes 
was gently mixed and placed in a twenty-five well automated thermal cycler 
(Appendorf) for amplification after properly placing the tubes tightly within the wells 
and closing the lid. The program with suitable set of temperatures was run. During this 
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procedure precautions were taken to keep the Taq polymerase active by not only 
preparing the reaction under 4
o
C temperature but also adding the various reaction 
components as quick as possible the PCR conditions were selected after extensively 
standardizing all the PCR parameters. Negative controls in all PCR assays consisted of 
a similar reaction mixture with the template replaced with sterile water. The primer 
pairs used for amplification were as follows:  
For codon 241 (exon 7) 
Forward primer: 5’ - GCTGTCTCGGGGCATGGCTC- 3’ 
Reverse primer: 5’ - ACGAGCTCAGGGGTGCAACC- 3’ 
The sequence of the ampl i f ied  f ragmen t ,   location o f  t he  SNP site and  
sequence  of the recognition site for the restriction enzyme were given in (Fig. 6) 
Table 4: Volume and final concentration of different reagents used in PCR 
Reagent* Volume required Final concentration 
   
1. PCR buffer (10X) 
2. dNTP mix 
3. Forward primer 
4. Reverse primer 
5.Taq DNA polymerase 
6. Genomic DNA 
7. Milli Q water 
2.5 µl 
0.5 µl 
0.5 µl 
0.5 µl 
0.75 µl 
2.5 µl 
17.75µl 
1X 
10mM 
20pmoles/µl 
20pmoles/µl 
1 U/ul 
50-100 ng 
- 
Total volume 25.0 µl  
   
* see appendix for these reagents 
Lyophilized primer stocks were diluted first to 100pmol/µl concentration and then to 
20pmol/µl using miliQ water. PCR buffer contained Tris-Cl, KCl, (NH4)2SO4 and 
15mM MgCl2; pH 8.7. Amplification and specificity of amplicon obtained in the PCR 
reaction was analyzed by agarose gel electrophoresis on 2% gel. After the 
electrophoresis, the gel was visualized on UV-illuminator and photographed on a Gel 
Doc (Pharmacia). 
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       The concentration of amplified PCR products was approximated by comparison 
with the corresponding bands in 100bp ladder. However, the total amount of 100bp 
DNA ladder in one lane was 200ng, representing approximate concentration of 33ng, 
8.8ng, 6.6ng, 4.4ng and 2.4ng respectively. 
  Table 5: PCR cycling parameters 
3.3.2. Restriction digestion 
The PCR product 208 b.p was digested with speciﬁc restriction enzymes for detecting 
the codon 241 polymorphism of the XRCC3 gene. The standard protocol for restriction 
digestion was used. Ten microliters of the PCR products were digested separately with 
5 units (0.5 microlitres) of Nla III for codon 241. The reaction mixture included 2 μl of 
10x buffer and 18 μl of Mili Q water. The mixture was incubated at 37°C for 24 h. The 
products were then resolved on 3% agarose gels. DNA molecular weight marker of 100 
bp was used to assess the size of the PCR–RFLP products.  
 
 
Step Temperature (
O
C) Time Cycles 
    
  1. Initial   
Denaturation 
94 10 min 1 
 2. Denaturation 94 30 sec. 30 
3. Annealing 66.5 45 sec 
4. Extension 72 1 min 
5. Final 
Extension 
72 10 min 1 
 32 cycles 
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3.3.3. DNA Sequencing of XRCC3 gene PCR products 
Ten percent of samples of both gastric cancer and healthy controls were sent for DNA 
sequencing (SciGenomics labs pvt. Ltd, Cochin).      
3.4. Statistical Analysis 
Results were statistically analyzed and data was expressed as mean±SD. Allele and 
genotype frequencies were compared between groups using the χ2-test. The association 
between XRCC3 genotype and the risk of Gastric cancer was estimated by calculating 
odds ratio (OR) and their 95% confidence intervals (95% CI). A P value of <0.05 was 
used as a criterion for statistical significance. For the analysis, statistical software 
GraphPad Prism version 5.0 was used. 
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4.1. General characteristics of Study Population 
In the present study 80 blood samples from gastric cancer patients (males and females) 
and 70 blood samples from healthy controls were used. General characteristics of the 
gastric cancer patients and controls are given in table 6. 
A total of 150 subjects were taken for the study from OPD/IPD Sections of SMHS 
Hospital Srinagar. The genotyping was carried out at Department of Biochemistry 
SMHS Hospital Srinagar. Among 150 subjects 80 were histopathalogical confirmed 
gastric cancer cases and 70 were healthy controls with age and sex matched. Among 80 
cases. 50 were ≥50 years and 30 were ≤ 50 years. Similarly, in 70 healthy controls, 45 
were ≥50 years and 25 were ≤ 50 years age. Gender wise, among 80 cases, 45 were 
males and 35 were females. In healthy controls, 55 were males and 15 were females . 
Mean age was  52.5 years for cases and 53.2 years for healthy controls; in the range of 
30-60 years for both cases and controls and sex-wise (56.2% males, 43.75% females in 
cases; 78.57 males, 21.43 females in controls) and these differences were not stastically 
significant, suggesting that the frequency matching was adequate. In addition there 
were no significant differences between cases and controls by non-genetic factors 
(Smoking, residence, salty tea consumption, family history of cancer). 
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Table 6: General characteristics of study population. 
 
 
 
         Variables 
  Cases 
    (80) 
  Controls 
   (70) 
P value 
 
Age 
≤ 50 50 (62.5) 45 (64.28)  
0.95 ≥ 50 30 (37.5) 25 (35.72) 
Gender 
Males 45 (56.25) 55 (78.57)  
0.006 
Females 35 (43.75) 15 (21.43) 
Smoking status 
Smoker 50 (62.5) 40 (57.14)  
0.61 
 
Non-smoker 30 (37.5) 30 (42.85) 
Residence 
Rural 45 (56.25) 40 (57.14)  
0.95 Urban 35 (43.73) 30 (42.85) 
Salty tea 
consumption 
Yes 50 (62.5) 45 (64.28)  
0.95 No 30 (37.5) 25 (35.72) 
Pickle 
consumption 
Yes 45 (56.25) 30 (42.85)  
0.14 No 35 (43.75) 40 (71.43) 
H. Pylori 
infection 
positive 45 (56.25) 20 (28.57)  
0.001 negative 35 (43.75) 50 (71.43) 
X-Ray radiation 
lifetime/once 
Yes 48 (60.0) 25 (35.71)  
0.005 Never 32 (40.0) 45 (64.28) 
Family history 
of cancer 
Yes 12 (15.0) 3 (4.28)  
0.05 No 68 (85.0) 67 (95.71) 
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4.2. Evaluation of DNA concentration and purification 
  The genomic DNA was extracted from the whole blood samples of cases and 
control patients. The integrity, concentration and purification of the genomic DNA was 
checked not only by UV- spectrophotometry but also by agarose gel electrophoresis, by 
analyzing 3-4µl of genomic DNA on the 0.8 % agarose gel (as shown in Fig. 9), which 
reflected the intactness of genomic DNA, because the genomic DNA was restricted to 
the wells with no smear in the gel suggesting that DNA was not degraded. The results 
showed that DNA concentration of the samples ranged from 300ng/µl to 1200 ng/µl 
which was sufficient enough to proceed for the other phases of the study. The purity of 
DNA was determined by A 260 / A280 ratio and it was found that the ratio in all DNA 
preparations was in the range of 1.73-1.85. Agarose gel electrophoresis also 
demonstrated that DNA samples had high molecular weight without degradation as 
shown in (Fig. 11). 
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Figure 11:  Representative gel picture showing the integrity of DNA analyzed by 
agarose gel electrophoresis (0.8%). Lane no.1- 4 represents DNA samples 
isolated from gastric cancer cases and lane no. 5, 6 represents DNA 
samples isolated from controls. 
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4.3. Amplification of codon 241 region of XRCC3 gene 
The genotyping of XRCC3 gene polymorphism was done by PCR. A primer sets 
were used to amplify the region containing the polymorphism in the XRCC3 gene. 80 
genomic DNA samples from gastric cancer patients (both males and females) and 70 
from normal subjects were randomly taken as DNA templates. The reaction conditions 
and PCR program which was used for amplification is described in methodology 
section. During PCR amplification, when all the PCR parameters were standardized 
and optimized, exon containing polymorphism was amplified. Using a primer pair, an 
amplicon representing exon 7 of codon 241 was produced. After efficient 
amplifications, 5-6µl of PCR product was analyzed on the 2.0% agarose gel. The 
amplified product was then visualized under UV exposure, using the ethidium bromide 
as visualizing agent. The result of PCR of exon 7 is shown in (Fig. 12). A single band 
of 208 bp was visible and represented exon 7 respectively 9 out of 80 genomic DNA 
from cases and 10 out of 70 genomic DNA from controls were not amplified properly 
and thus could not get desired results. 
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Fig. 12:  Representative gel picture showing PCR results of XRCC3 gene exon7.   Lane no. 
1, represents blank whereas lane 2, 3, 7, represents 208 bp PCR amplicon of GC 
cases and lane 4, 5, 6 represent 208 bp PCR amplicon of controls.  Lane M 
contains 100 bp DNA ladder. 
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4.4. Restriction digestion for the codon polymorphism of the XRCC3 gene 
       For the detection of polymorphism in codon 241 of XRCC3 gene PCR product, 
restriction digestion was performed, which was digested with a restriction enzyme Nla 
III. The enzyme Nla III recognizes the wild type alleles of codon 241. The PCR product 
of 208 bp was digested for codon 241 polymorphism by the standard restriction 
digestion protocol discussed in methodology in both GC Cases and controls. The 
product was then resolved on 3% agarose gels. Among 80 GC Cases 60 samples 
remains uncut (homozygous wild) by Nla111  restriction enzyme, 10 were digested 
(heterozygous)  having three bands 208bp, 120bp and 88 bp, only 1 sample was 
digested into two bands 120 bp and 88 bp (mutant homozygous). Same  was done in  70 
controls were 52 samples remains uncut (homozygous wild) by Nla111  restriction 
enzyme, 8 were digested (heterozygous)  into  three bands 208bp, 120bp and 88 bp, and 
none shows mutant homozygous condition (Fig. 13) . The fidelity of restriction enzyme 
was cross checked in order to rule out the possibility of enzymatic inactivity. The 
results thus obtained were further validated by the sequencing report of samples that 
showed no variation (Fig. 14a-15b). The XRCC3 gene was monomorphic for suspected 
polymorphism in our population as no major mutant homozygous condition was 
observed in either cases or controls. 
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L1-Represents Ladder 50 bp     
Lane 2-Represents heterozygous genotypes (Three bands at 208bp,120bp, 88 bp)in 
Controls. 
Lane 3 -Represents heterozygous genotypes (Three bands at 208bp,120bp, 88 bp)in 
Cases  
Lane 4-Represents mutant homozygous genotype (Two bands 120bp, 88 bp) in cases 
lane  5-Represents Wild homozygous genotypes (one band  at 208 bp) in cases. 
Lane 6-Represents Wild homozygous genotypes (one band  at 208 bp) in Controls. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 13  Representative gel picture of XRCC3 Exon7 gene restriction digestion by NLAIII 
restriction enzyme, on agarose gel 3%. 
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Sequencing result for XRCC3 gene exon7: 
 
 
 
Fig. 14 (a):  Representative chromatogram of direct sequencing for XRCC3 gene exon7 241 
codon in controls. 
 
 
 
 
Fig. 14 (b): Representative chromatogram of Direct sequencing for XRCC3 gene exon7 241 
codon in GC cases.. 
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Fig. 15 (a): Partial sequence electropherogram showing wild type homozygous XRCC3 exon 7 
241 codon in normal controls. 
 
 
 
 
 
 
 
Fig. 15 (b) : Partial sequence electropherogram showing wild type homozygous XRCC3 exon7 
241 codon  in  GC cases. 
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Table. 7. Genotypic and allelic frequencies of XRCC3 gene codon 241 among case and 
controls and their association with risk of gastric cancer 
 
Gene Variants Cases (n=80) 
Controls 
(n=70) 
 
 
χ2 
 
OR 
(95%CI) 
 
p value 
XRCC3 
(codon 
241) 
Thr/Thr 60 (75%) 52 (74.2%) - 1 referent 
Thr/Met 10 (12.5%) 8 (11.4%) 0.009 
1.08  
(0.39 - 2.49) 
0.92 
Met/Met 1 (1.25%) 0 0.006 
2.60    
(0.10 – 65.33) 
0.93 
Thr 130 (91.5%) 112 (93.3%) - 1 referent 
Met 12 (8.7%) 8 (6.66%) 0.08 
1.13    
(0.58 – 2.1) 
0.72 
Thr/Met + 
Met/Met 
11 (13.75%) 8 (11.42%) 0.01 
1.19  
 (0.44 - 3.18) 
0.89 
 
Missing 
result 
9 
 
10 
   
 
As shown in (Table.7) and histogram (Fig. 16) , no significant differences were 
observed for either the frequency of XRCC3 241Thr/Met genotype or the frequency of 
241Met allele between cases and controls (12.5% of 241Thr/Met in cases, and 11.4% in 
controls, P=0.92; 8.7% of Met allele in cases and 6.6% in controls, P=0.72). Compared 
with 241Thr/Thr wild-type genotype, the XRCC3 241Thr/Met was not associated an 
increased risk of gastric cancer in the logistic regression analysis (adjusted 
OR=1.08:95%CI=0.39-2.49,P=0.92). Because, the XRCC3 241Met/Met genotype was 
infrequent in this Kashmiri population, it was combined with the XRCC3 241Thr/Met 
Genotype. However, the combined genotype (Met/Met and Thr/Met) in (Table. 7),   
was also not associated with the risk of gastric cancer (OR=1.19;95% CI=0.44-
3.18,P=0.89). The dichotomized genotypes (XRCC3 241Thr/Met or Met/Met vs 
Thr/Thr) were further examined individually for subgroups of the variables listed in 
(Table. 8) and adjusted odd ratio with 95% confidence intervals are presented in (Table. 
8) , were p valve was greater than 0.05, that means association insignificant in these 
subgroups.  
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Table . 8.  Stratification analysis of XRCC3 genotype frequencies of non-genetic factors in gastric cancer. 
 
 
 
 
Variable 
Cases=80 Controls=70  
OR* 
 
95%CI 
 
P-Value 
 
n 
 
Thr/Thr 
 
Thr/Met 
 
Met/Met 
 
n 
 
Thr/Thr 
 
Thr/Met 
 
Met/Met 
Age 
 
>50 
 
<50 
 
 
 
50 
 
30 
 
 
32(64.0) 
 
24(80.0) 
 
 
15(30.0) 
 
4(13.3) 
 
 
1(2) 
 
0 
 
 
45 
 
25 
 
 
36(80.0) 
 
13(52.0) 
 
 
8(17.7) 
 
7(28.0) 
 
 
0 
 
0 
 
 
2.38(0.85-6.69) 
0.31(0.07-1.26) 
 
 
0.20 
 
0.18 
Sex 
 
Male 
 
Female 
 
 
 
 
 
45 
 
35 
 
 
 
28(62.2) 
 
29(82.8) 
 
 
 
13(28.8) 
 
5(14.2) 
 
 
 
1(2) 
 
0 
 
 
 
55 
 
15 
 
 
 
42(76.3) 
 
9(60.0) 
 
 
 
12(21.8) 
 
3(20.0) 
 
 
 
0 
 
0 
 
 
 
1.62(0.64-4.07) 
0.51(0.10-2.60) 
 
 
 
0.42 
 
0.71 
Smoke 
 
Yes 
 
No 
 
 
 
 
 
50 
 
30 
 
 
 
30(60.0) 
 
26(86.6) 
 
 
 
15(30.0) 
 
3(10.0) 
 
 
 
1(2) 
 
0 
 
 
 
40 
 
30 
 
 
 
31(77.5) 
 
20(66.6) 
 
 
 
7(17.5) 
 
8(26.6) 
 
 
 
0 
 
0 
 
 
 
2.21(0.79-6.19) 
0.28(0.06-1.23) 
 
 
 
0.19 
 
0.16 
Salty Tea 
Yes 
 
No 
 
 
 
50 
 
30 
 
33(66.0) 
 
25(83.3) 
 
14(28.0) 
 
4(13.3) 
 
1(2) 
 
0 
 
45 
 
25 
 
36(80.0) 
 
16(64.0) 
 
7(15.5) 
 
8(32.0) 
 
0 
 
0 
 
2.18(0.78-6.07) 
0.32(0.08-1.24) 
 
0.20 
 
0.17 
Pickle consumer 
 
 
Yes 
 
 
 
 
45 
 
 
 
 
29(64.4) 
 
 
 
 
13(28.8) 
 
 
 
 
1 
 
 
 
 
30 
 
 
 
 
21(70.0) 
 
 
 
 
8(26.6) 
 
 
 
 
0 
 
 
 
 
1.17(0.41-3.34) 
0.76(0.21-2.67) 
 
 
 
0.96 
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No 
 
35 29(82.8) 5(14.2) 0 40 31(77.5) 7(17.5) 0 0.91 
 
Residence 
 
Urban 
 
Rural 
 
 
45 
 
35 
 
 
 
32(71.1) 
 
26(74.2) 
 
 
12(26.6) 
 
6(17.1) 
 
 
1(2) 
 
0 
 
 
40 
 
30 
 
 
29(72.5) 
 
22(73.3) 
 
 
9(22.5) 
 
6(20.0) 
 
 
0 
 
0 
 
 
1.20(0.44-3.28) 
0.84(0.23-3.0) 
 
 
0.90 
 
0.95 
 
*ORs were adjusted for age, sex, smoking, residence, tea consumption, H. pylori infection and family history of cancer in a logistic regression model.  
Thr/Thr (1.00) was taken as referent. 
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Fig. 16:  Histogram showing the distribution of XRCC3 genotypes in cases and control 
               population. 
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Gastric cancer is the second most frequent malignancy worldwide accounting 
for 9.9% of all cancer incidences and 12.1% of all cancer deaths. Gastric cancer, can 
develop in any part of stomach and may spread throughout the stomach and other 
organs of gastrointestinal tract like, esophagus, liver, colon etc. GC costs 80,000 deaths 
worldwide per year (Parkin et al., 2010). Therefore, prognosis for gastric cancer 
patients remains poor as most patients are diagnosed in advanced stages. Studies have 
shown incidence rates in men are twofold than those in women. In the Kashmir valley, 
gastric cancer has emerged as the most common cancer, forming about 25% of all 
cancers (Parkin et al., 2001). Kashmir valley, has greater malignancy rate and the 
incidence rates in southern district of Kashmir are higher (Khuroo et al., 1992). Genetic 
polymorphism in DNA repair genes influences individual variation in DNA repair 
capacity, which has been associated with risk of developing cancer (Boer et al., 2002, 
Ruzzo et al., 2007). Xenobiotics (nitrates, nitrosamines, nitrites, heterocyclic amines 
and polycyclic hydrocarbons), ionizing radiations (UV,IR, X-Ray), life style factors 
(smoking, tobacco eating, alchol drinking, salty tea with sodium bicarbonate) and 
environmental chemical agents cause double strand DNA –breaks in some candidate 
genes (Siddiqi et al.,1992, Malik et al., 2011). 
The XRCC3 repair genes have been reported to play an essential role in 
homologous recombination repair (HRR) in mammalian cells (Cui et al., 1999, 
Hoeijimakers et al., 2001). XRCC3 is located on chromosome 14q32.3. In HR 
pathway, XRCC3 is structurally related to RAD51 gene family to localize at sites of 
DSB damage and subsequently functions to promote the assembly of active RAD51 
repair complexes, namely RAD51 foci (Ohgaki et al., 2003, Sathornsumetee et al., 
2007). Once RAD51 foci are formed, mammalian cells use the sister chromatids as the 
template of preference over a homologous chromosome. Lack of the XRCC3 gene will 
result in decreased function of HR (Vangent  et al., 2001, Sathornsumetee et al., 2007) 
and defects in chromosome segregation (Thompson et al.,2001). Hence, XRCC3 gene 
mediates RAD51 dependent HR necessary to repair DNA damage that may result in 
carcinogenesis if left untreated or misrepaired. Carriers of the variant allele of XRCC3 
Thr241Met had relatively high DNA adduct levels in lymphocyte DNA, indicating that 
this polymorphism has been associated with relatively low DNA repair capacity 
(Griffin et al., 2004). Therefore, XRCC3 gene has been of considerable interest as a 
candidate susceptibility gene for cancer. The XRCC3 gene has a sequence variation in 
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exon7, which results in an aminoacid substitution at codon 241(Thr241Met) that affects 
the enzymes function and its interaction with other proteins involved in DNA damage 
and repair (Matullo et al., 2001). Our aim was to study the XRCC3 exon7 (Thr241Met) 
single nucleotide polymorphism (SNP) in gastric cancer risk. 
In the present hospital based case-control study, of XRCC3 gene codon 241 
polymorphism (Thr241met; C/T Transition) in 80 histopathologically gastric cancer 
patients and 70 healthy controls  has been analyzed at Department of Biochemistry, 
GMC Srinagar. Very few studies have investigated the role of polymorphisms of the 
DNA repair genes XRCC3 in the risk of gastric cancer. A case-control study was 
conducted  to investigate the association between the polymorphism of XRCC3 
Thr241Met with the risk of gastric cancer in a Kashmiri population. This 
polymorphism results in amino acid substitution of DNA repair genes involved in 
HRR. DNA repair pathways play a vital role in maintaining genetic integrity and it is 
becoming clear that defects in repair pathways are connected to many different types of 
diseases. DNA repair systems maintain genomic integrity, in the face of environmental 
insults, cumulative effects of age and general DNA replication errors. In our case 
control study, a single nucleotide polymorphism (SNP) in the XRCC3 gene and its 
association with gastric cancer was investigated in total 150 subjects, among 80 were 
gastric cancer cases and 70 were  apparently normal controls. The polymorphism 
assessed, was not present in codon 241. Each polymorphism in the 241 codon of the 
human XRCC3 gene was composed either of two types of alleles – the wild type or 
polymorphic variant type with different RFLP size distributions. Thr/Thr was the wild 
type allele present in codon 241 and Thr/Met was a heterozygous variant present in this 
particular codon and Met/Met represents homozygous mutant. Out of these alleles, the 
frequency of homozygous mutant allele Met/Met was lower for codon 241 (8.7% vs. 
6.6%) in patients as compared to control subjects. In codon 241 polymorphism, out of 
80 gastric cancer subjects, 1 case was found to be homozygous for Met/Met 
polymorphic allele, 10 were heterozygous while 60 were homozygous for Thr/Thr wild 
allele as compared to 0, 8 and 52 in case of 70 normal subjects respectively. In this 
codon 241 polymorphism, we found that number of Met alleles were present equally 
less (8.7% vs. 6.6%) in cases as compared with controls. Cases with codon241 Thr/Thr 
homozygous variant had an slight increased frequency of 75% vs. 74.2% in controls but 
a slight increased frequency was also observed  in cases with heterozygous variant 
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Thr/Met of codon241 (12.5% Vs. 11.4%) as compared with controls (OR= 1.08, 95% 
CI = 0.39 - 2.49, P = 0.92 ),  however it was not statistically significant. In the case of 
the homozygous variants of codon241 Met/Met genotype, 1.25% in cases was 
observed,  as compared to healthy controls 0% (OR = 2.60, 95% CI = 0.10 – 65.33, P = 
0.93 ), which was also statistically insigniﬁcant. In all the three variant forms, the 
Thr/Thr wild type allele was taken as the referent category. Moreover the Met allele of 
codon241 showed a slight increased frequency in cases (8.7% vs. 6.6%) in comparison 
with controls (OR= 1.13, 95% CI = 0.58 – 2.1, P = 0.72), this also having a statistically 
insignificant result. This proves, there is no association of XRCC3 Gene in gastric 
cancer risk. A statistically insignificant interaction
 
between non-genetic factors (age, 
sex, smoking status, residence, pickle consumption, radiation exposure, family history 
of cancer) was also observed.  P value was ≥0.05 that means association insignificant 
(Table. 8).  
In this case control study, it was observed that most of the cases belong to above 
50 years of age rather than with below 50 years of age. We calculated the total number 
of polymorphic variants in case of below 50 years old (Thr/Thr as well as Met/Met) 
was calculated, as their individual genotype was less in number. However, the result 
was not statistically significant. Moreover, distribution of patients into various subtypes 
of gastric cancer also indicated that majority of patients suffered from squamous cell 
and adeno carcinoma.  
In this population-based case-control study in Kashmiri subjects, it was found 
that a C toT variant (Thr241Met) of DNA repair gene XRCC3 was not associated with 
risk of developing gastric cancer, suggesting that the variant genotype of XRCC3 
codon241 may not play a major role in the etiology of gastric cancer. To the best of our 
knowledge, this is the first report on this XRCC3 Thr241Met polymorphism in a 
Kashmiri population. It was found that the frequency of 241 Met allele was 
significantly lower in this Kashmiri population than that reported in Caucasians 
(G.David et al., 2001). Several studies have examined the association between the 
XRCC3Thr241Met polymorphism and risk of cancers (Matullo et al., 2001, Kuschel et 
al., 2002, Winsey et al., 2000, Duan et al., 2002, Ster et al., 2002). However, other 
studies found that the XRCC3 241Met variant allele was not associated with risk of 
gastric, lung, colon, head/neck in Chinese, European, Brazillian population (G David et 
al., 2001, Shenhongbin et al., 2004, Improtal et al., 2009, Fang et al., 2010). Genetic 
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polymorphisms often vary between ethnic populations. In the 70 healthy controls of 
Kashmiri subjects, we did not observed the XRCC3241Met/Met homozygous 
genotypes and the frequency of 241Met allele was 6.6%. Both XRCC3 codon 241 
varaiant genotypes and allele frequencies in this Kashmiri populations were 
significantly lower than those reported for the control subjects in previous studies in 
Caucasians (David et al., 2001, Matullo et al., 2001, Kuschel et al., 2002, Winsey et 
al., 2000, Duan et al., 2002, Stern et al., 2002). 
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Conclusion  
There are lot of contradictions with the gene XRCC3 in different cancers with 
different ethnicity. In India, no reports of any study of this gene XRCC3 exon 7 
(Thr241Met) in gastric cancer are reported. This study from north-India’s Kashmir 
valley, is a first report of its kind that the XRCC3 gene has no association with gastric 
cancer risk. Similar observations are also reported from, China, Europe, Italy and Brazil 
(G David et al., 2001, Shenhongbin et al., 2004, Improtal et al., 2009, Fang et al., 
2010). Therefore, lack of association between the XRCC3241Met variant and risk of 
gastric cancer is not surprising. One possible explanation is that the 241met variant in 
this low-penetrance gene may not be an important determinant in the etiology of gastric 
cancer. It is also likely that many variants or common susceptibility polymorphisms, 
not just single one, of DNA repair genes may jointly contribute to the susceptibility of 
gastric cancer. Therefore, it is important to include more variants in the genes that 
participate in the same DNA repair pathways in order to identify genetic markers as 
well as gene-gene and gene-environment interactions that may predict individual 
susceptibility to gastric cancer. Further study on larger samples is needed not in gastric 
cancer alone but in different cancers as well.  
 
 
 
 
APPENDIX 
 
        CHEMICALS AND REAGENTS 
        CHEMICALS 
Chemical Name Company 
Absolute ethanol BENGAL CHEMICALS 
Acetone GALAXO LABORATORIES 
Agarose MP BIOMEDICALS 
Ammonium  chloride BDH 
Ammonium acetate BDH 
Bromophenol blue SARABHAI  M  CHEMICALS 
Chloroform THOMAS BAKERS 
De Ionized water ALFA LABORATORIES 
Ethidium bromide SRL 
Ethyl acetate MERCK 
Ethylene diamine tetra acetate (EDTA) LOBA CHEMIE 
Formaldehyde GALAXO LABORATORIES 
Glacial Acetic acid MERCK 
Hydrochloric acid S D FINE CHEMICALS 
Hydrogen peroxide MERCK 
8-Hydroxyquinoline CDH 
Isoamyl alcohol BDH 
Isopropanol THOMAS BAKERS 
Magnesium chloride MERCK 
Methanol SARABHAI  M  CHEMICALS 
Phenol  SRL 
Potassium acetate QUALIGENS 
Potassium bicarbonate QUALIGENS 
Potassium chloride LOBA- CHEMIE 
Potassium hydroxide S D FINE CHEMICALS 
2-Propanol MERCK 
Sodium acetate SARABHAI  M  CHEMICALS 
Sodium azide LOBA CHEMIE 
Sodiun bisulphate LOBA CHEMIE 
Sodium carbonate FIZMERCK 
Sodium chloride MERCK 
Sodium dodecyl sulphate MP BIOMEDICALS 
Sodium hydroxide HIMEDIA 
Sodium hydrogen carbonate LOBA- CHEMIE 
Sodium phosphate dibasic LOBA- CHEMIE 
Sodiun thiosulfate LOBA CHEMIE 
Sucrose QUALIGENS 
Sulfuric acid MERCK 
TE buffer SRL 
Tris base SIGMA CHEMICAL COMPANY 
Tris HCL HIMEDIA 
Triton X 100 S D FINE CHEMICALS 
 
ENZYMES 
 
Taq polymerase FERMENTAS /  BIOTOOLS 
Proteinase K 
NLA III 
ZYMO RESEARCH 
FERMENTAS 
 
MISCELLANEOUS  MATERIAL  
100bp DNA ladder FERMENTAS / BIO ENZYME 
 
PCR  REAGENTS  
10 X Buffer (with Mgcl2) BIOTOOLS 
dNTPs CINNAGEN 
Primers  MERCK GERMANY 
 
 
DNA storage buffer: 
0.5 M EDTA        0.01 ml 
1 M Tris        0.5 ml 
Final volume was made 50 ml with sterile distilled water. 
 
 
REAGENTS FOR AGAROSE GEL ELECTROPHORESIS: 
Agarose 1 % / 2%/3%:      
Agarose        0.5g  / 1.0g 
Buffer         50ml 
Ethidium bromide       10µl 
Agarose was dissolved in a buffer and heated till a clear solution is formed. Ethidium 
bromide was then added to the solution during its cooling just before being poured into the 
casting tray. 
 
Bromophenol Blue: 
Bromophenol Blue       0.4g 
Sucrose        20.0g 
Bromophenol blue was dissolved in 100ml of distilled water. 
From the above stock solution 31.25ml was taken and sucrose was added. Final volume was 
made 50ml with distilled water. 
 
 
Ethidium Bromide 
Ethidium bromide       10mg 
Ethidium Bromide was dissolved in 1ml of distilled water. The solution was stored in a dark 
bottle at 4˚C. 
 
50-X TAE (pH 8.0) STOCK SOLUTION: 
Tris base        242g 
0.5M EDTA        100ml 
Glacial acetic acid       57.1ml 
Final volume was made 1000ml with distilled water. This is stock solution. 
 
1-X  TAE (pH 8.0) WORKING SOLUTION: 
50-X  TAE        20ml 
Final volume was made 1000ml with distilled water. 
 
Reagents for PCR: 
Stock 
Deoxyribose Nucleotide Triphosphate (dNTP) 100mM each  dATP,  dGTP,  dCTP  and 
dTTP. 
Taq polymerase (5U/µl) 
10X Taq buffer  (16 mmol/L Ammonium sulphate; 67 mM/L Tris- HCL, pH 8.8; 10 mM/L  
2-Mercaptoethanol); 6.7 mM/ L MgCl2) 
Primers: 100pM in sterile deionised water (Genescript)  
100bp DNA ladder (0.5µg/µl) 
50 bp DNA ladder(0. 5µg/µl) 
 
Reagents for RFLP: 
 
MILLI Q,  NLA III (Restriction enzyme ) and buffer. 
.  
 
 
 
